研究紹介  業績

業績

2014

Aibe N, Yamazaki H, Nishimura T, Oota Y, Iwama K, Nakamura S, Ikeno H, Yoshida K, Okabe H, Yamada K. Analysis of Intrafractional Organ Motion by Megavoltage Computed Tomography in Patients with Lung Cancer Treated with Image-guided Stereotactic Body Radiotherapy Using Helical Tomotherapy. Anticancer Res. 34(12):7383-8, 2014. [Pubmed]

Aibe N, Yamazaki H, Nakamura S, Tsubokura T, Kobayashi K, Kodani N, Nishimura T, Okabe H, Yamada K. Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis. J Radiat Res. 55(3):575-82, 2014. [Pubmed]

Aoki-Nakano M, Furusawa Y, Uzawa A, Matsumoto Y, Hirayama R, Tsuruoka C, Ogino T, Nishio T, Kagawa K, Murakami M, Kagiya G, Kume K, Hatashita M, Fukuda S, Yamamoto K, Fuji H, Murayama S, Hata M, Sakae T, Matsumoto H. Relative biological effectiveness of therapeutic proton beams for HSG cells at Japanese proton therapy facilities. J Radiat Res. 55(4):812-5, 2014.[Pubmed]

 

Akino Y, Oh RJ, Masai N, Shiomi H, Inoue T. Evaluation of potential internal target volume of liver tumors using cine-MRI. Med phys. 41(11):111704, 2014.[Pubmed]

Akiyama H, Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Masui K, Yoshioka Y, Arika T, Shimizutani K, Tanaka E. High-dose-rate interstitial brachytherapy for mobile tongue cancer: preliminary results of a dose reduction trial. J Contemp Brachytherapy. 6:10-4, 2014.[Pubmed]

Brett-Morris A, Wright BM, Seo Y, Pasupuleti V, Zhang J, Lu J, Spina R, Bar EE, Gujrati M, Schur R, Lu ZR, Welford SM. The polyamine catabolic enzyme SAT1 modulates tumorigenesis and radiation response in GBM. Cancer Res 74(23): 6925?34, 2014.[Pubmed]

Chatani M, Tsuboi K, Yagi M, Fujiwara K, Tachimoto R. Radiation therapy for carcinoma of the uterine cervix: comparison of two brachytherapy schedules J Radiat Res. 55:748-753, 2014.[Pubmed]

Fuji H, Yoshikawa S, Kasami M, Murayama S, Onitsuka T, Kashiwagi H, Kiyohara Y. High-dose proton beam therapy for sinonasal mucosal malignant melanoma, Radiation Oncology. 9:162-168, 2014.[Pubmed]

Fujiwara M, Isohashi F, Mabuchi S, Yoshioka Y, Seo Y, Suzuki O, Sunida I, Hayashi K, Kimura T, Ogawa K.. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO stage IB2?IVA cervical cancer and its clinical prognostic factors. J Radiat Res. 56(2):305-14. 2014.[Pubmed]

Fukuda S, Seo Y, Shiomi H, Ymamada Y, Ogata T, Morimoto M, Konishi K, Yoshioka Y, Ogawa K. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife. J Radiat Res. 55(6):1114-21,2014.[Pubmed]

Gamoh S, Mori Y, Nakatsuka M, Akiyama H, Ogawa Y, Iwai Y, Morita S, Shimizutani K. Accessory mental foramen misdiagnosed as radiolucent tumour by conventional dental radiography. Open Journal of Stomatology, 3: 173-146, 2014

Gamoh S, Kawaue Y, Akiyama H, Nakashima Y, Hida T, Tsuji K, Mori Y, Shimizutani K. Assessment of lingual foramina on various image modalities: retrospective study essential to surgery in anterior portion of the mandible. Journal of Japanese Society of Oral Implantology, 27 (2): 156-163, 2014

Gamoh S, Nakashima Y, Akiyama H, Tsuji K, Yamada K, Suzuki M, Morita S, Shimizutani K. Fibrosarcoma of the temporomandibular joint area: benefits of magnetic resonance imaging and computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol, 2014.118(3): 262-266, 2014.[Pubmed]

Hamamura K, Minami K, Tanjung N, Wan Q, Koizumi M, Matsuura N, Na S, Yokota H. Attenuation of malignant phenotypes of breast cancer cells through eIF2α-mediateddownregulation of Rac1 signaling. Int J Oncol. 44(6):1980-8, 2014.[Pubmed]

Hanamoto A, Tatsumi M, Takanaka Y, Hamasaki T, Yasui T, Nakahara S, Yamamoto Y, Isohashi F, Seo Y, Ogawa K, Hatazawa J, Inohara H. Volumetric PET/CT Parameters Predict Local Response of Head and Neck Squamous Cell Carcinoma to Chemoradiotherapy. Cancer Med. 3(5):1368-76,2014.[Pubmed]

 

Hayashi K, Araki N, Koizumi M, Suzuki O, Seo Y, Naka N, Isohashi F, Myoui A, Yoshioka Y, Teshima T, Ueda T, Yoshikawa H, Ogawa K. Long-term results of intraoperative extracorporeal irradiation of autogenous bone grafts on primary bone and soft tissue malignancies. Acta. Oncol. 16: 1-4, 2014.[Pubmed]

Hayashi K, Tamari K, Ishii H, Konno M, Nishida N, Kawamoto K, Koseki J, Fukusumi T, Kano Y, Nishikawa S, Miyo M, Noguchi K, Ogawa H, Hamabe A, Seo Y, Doki Y, Mori M, Ogawa K. Visualization and characterization of cancer stem-like cells in cervical cancer. Int J Oncol. 45(6):2468-74,2014.[Pubmed]

Hayashi Y, Nishida T, Tsujii M, Tsutsui S, Yamamoto K, Isohashi F, Yamasaki M, Miyata H, Kato M, Yamada T, Shinzaki S, Iijima H, Ogawa K, Doki Y, Takehara T. Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma. BMC Cancer. 14(1):706,2014.[Pubmed]

Hiraki M, Nishimura J, Ohtsuka M, Shiomi H, Uemura M, Haraguchi N, Hata T, Hayashi T, Takemasa I, Mizushima T, Isohashi F, Yoshioka Y, Ogawa K, Doki Y, Mori M, Yamamoto H. Impact of stereotactic body radiotherapy on colorectal cancer with distant metastases. Oncol Rep. 31(2):795-9,2014.[Pubmed]

Inoue M, Shiomi H. Sato K, Taguchi J, Okawa K, Inada K, Murai T, Koike I, Tatewaki K, Ota S, Inoue T. Effect of residual patient motion on dose distribution during image-guided robotic radiosurgery for skull tracking based on log file analysis. Jpn J Radiol. 32(8): 461-6, 2014.[Pubmed]

Inoue M, Konno M, Ogawa H, Harada H, Asakura H, Fuji H, Murayama S, Nishimura T. A simpler method for total scalp irradiation: the multijaw-size concave arc technique. J Appl Clin Med Phys.15(4):4786, 2014.[Pubmed]

Inoue T, Masai N, Oh R, Shiomi H, Hashida N. Adaptive replanning intensity-modulated radiotherapy for choroidal metastasis of breast cancer using optical coherence tomography. J Radiat Res. 55(3): 502-8, 2014.[Pubmed]

Ishitobi M, Suzuki O, Komoike Y, Ohsumi S, Nakahara S, Yagi T, Yoshinami T, Tomita Y, Inaji H. Phase II study of neoadjuvant anastrozole and concurrent radiotherapy for postmenopausal breast cancer patients. Breast Cancer. 5:550-6, 2014.[Pubmed]

Iwama K, Yamazaki H, Nishimura T, Oota Y, Aibe N, Nakamura S, Ikeno H, Yoshida K, Okabe H. Frequency and predisposing factors for interfractional rectal displacement requiring repeated precaution in prostate cancer patients treated with image-guided intensity-modulated radiation therapy. Anticancer Res. 34(12):7373-8, 2014.[Pubmed]

Kakimoto N, Shimamoto H, Chindasombatjaroen J, Tsujimoto T, Tomita S, Hasegawa Y, Murakami S, Furukawa S. Comparison of the T2 relaxation time of the temporomandibular joint articular disk between patients with temporomandibular disorders and asymptomatic volunteers.AJNR Am J Neuroradiol.35(7):1412-7, 2014.[Pubmed]

Kano Y, Konno M, Kawamoto K, Tamari K, Hayashi K, Fukusumi T, Satoh T, Tanaka S, Ogawa K, Mori M, Doki Y, Ishii H.. Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus. Oncol Rep. 31(3):1133-8,2014.[Pubmed]

Mabuchi S, Takahashi R, Isohashi F, Yokoi T, Okazawa M, Sasano T, Maruoka S, Anzai M, Yoshioka Y, Ogawa K, Kimura T. Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience. Int J Gynecol Cancer. 24(1):141-8,2014.[Pubmed]

Mabuchi S, Matsumoto Y, Kawano M, Minami K, Seo Y, Sasano T, Takahashi R, Kuroda H, Hisamatsu T, Kakigano A, Hayashi M, Sawada K, Hamasaki T, Morii E, Kurachi H, Matsuura N, Kimura T. Uterine cervical cancer displaying tumor-related leukocytosis: a distinct clinical entity with radioresistant feature. J Natl Cancer Inst 106(7): 1?11, 2014.[Pubmed]

Masui K, Yoshida K, Takenaka T, Kotsuma T, Tanaka E, Tatsumi K, Yamazaki H, Yamada K. A novel minimally invasive technique of high-dose rate image-based intracavitary brachytherapy for endometrial cancer using a single fine and soft, flexible applicator. Anticancer Res. 34(5):2537-40, 2014.[Pubmed]

Miura H, Masai N, Oh RJ, Shiomi H, Yamada K, Sasaki J, Inoue T. Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy. J Appl Clin Med Phys.15(1):4202, 2014.[Pubmed]

Miura H, Oh RJ, Masai N, Shiomi H, Yamada K, Inoue T. Lung stereotactic body radiotherapy under the use of abdominal compression system "Air-bag system". IJMPCERO. 3(2): 98-106, 2014.[Pubmed]

Miura H, Masai N, Yamada K, Sasaki J, Oh RJ, Shiomi H, Usmani MN, Inoue T. Evaluation and commissioning of commercial Monte Carlo dose algorithm for air cavity. IJMPCERO. 3(1): 9-13, 2014 

Miura H, Masai N, Oh RJ, Shiomi H, Yamada K, Sasaki J, Usmani MN, Inoue T. Dosimetric comparison of different target dose prescriptions in stereotactic body radiation therapy for lung cancer. International Journal of Medical Physics, IJMPCERO. 3(1): 14-9, 2014

Miura H, Masai N, Oh RJ, Shiomi H, Yamada K, Usmani MN, Inoue T. Dosimetric impact of tumor position and lung density variations in lung stereotactic body radiotherapy. IJMPCERO. 3(1); 43-8, 2014

Miura H, Inoue T, Shiomi H, Oh RJ. Differences in rates of radiation-induced true and false rib fractures after stereotactic body radiation therapy for Stage I primary lung cancer. J Radiat Res. Mar;56(2):332-7,2015.[Pubmed]

Morimoto M, Yoshioka Y, Konishi K, Isohashi F, Takahashi Y, Ogata T, Koizumi M, Teshima T, Bijl HP, van der Schaaf A, Langendijk JA, Ogawa K.. Comparison of acute, subacute genitourinary and gastrointestinal adverse events of radiotherapy for prostate cancer using intensity modulated radiation therapy, three-dimensional conformal radiation therapy, permanent implant brachytherapy or high-dose-rate brachytherapy. Tumori. 100(3):265-71,2014.[Pubmed]

Morimoto M, Isohashi F, Yoshioka Y, Suzuki O, Seo Y, Ogata T, Akino Y, Koizumi, Ogawa K. Salvage high-dose-rate interstitial brachytherapy for locally recurrent rectal cancer: long-term follow-up results. Int J Clin Oncol 19(2):312-8, 2014.[Pubmed]

Nishimura T, Yamazaki H, Iwama K, Oota Y, Aibe N, Nakamura S, Yoshida K, Okabe H, Yamada K. Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report. J Med Case Rep. 8:136, 2014.[Pubmed]

Nishino K, Shimamoto H, Kakimoto N, Tsujimoto T, Chindasombatjaroen J, Murakami S, Furukawa S. Influence of an object's z-axis location and location on the axial plane on the voxel value representation and uniformity in cone beam computed tomography.Oral Surg Oral Med Oral Pathol Oral Radiol.118(5):619-24, 2014.[Pubmed]

Okahata R, Shimamoto H, Marutani K, Tomita S, Nakatani A, Kishino M, Kakimoto N, Murakami S, Furukawa S. Diffuse large B-cell lymphoma of the mandible with periosteal reaction: a case report.Oral Surg Oral Med Oral Pathol Oral Radiol.117(2):e228-32, 2014.[Pubmed]

Otani K, Nishiyama K, Ito Y, Kawaguchi Y, Inaji H, Steroid treatment increases the recurrence of radiation-induced organizing pneumonia after breast-conserving therapy. Cancer Medicine. 3(4):947-53, 2014.[Pubmed]

Shibamoto Y, Sumi M, Onodera S, Matsushita H, Sugie C, Tamaki Y, Onishi H, Abe E, Koizumi M, Miyawaki D, Kubota S, Ogo E, Nomiya T,Takemoto M, Harada H, Takahashi I, Ohmori Y, Ishibashi N, Tokumaru S, Suzuki K. Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Int J Clin Oncol 19(5):963-71, 2014.[Pubmed]

Sumida I, Yamaguchi H, Kizaki H, Aboshi K, Yamada Y, Yoshioka Y, Ogawa K.. Three-dimensional dose prediction based on two-dimensional verification measurements for IMRT. J Appl Clin Med Phys. 15(5):4874,2014.[Pubmed]

Sumida I, Yamaguchi H, Kizaki H, Yamada Y, Koizumi M, Yoshioka Y, Ogawa K, Kakimoto N, Murakami S, Furukawa S. Evaluation of imaging performance for megavoltage cone-beam CT over an extended period.J Radiat Res. 55(1):191-9,2014.[Pubmed]

Suzuki G, Yamazaki H, Ogo E, Abe T, Eto H, Muraki K, Hattori C, Umeno H, Tanaka N, Tanaka T, Nakamura S, Yoshida K. Predisposing Factors for Larynx Preservation Strategies with Non-surgical Multimodality Treatment for Locally Advanced (T3-4) Larynx, Hypopharynx and Cervical Esophageal Disease. Anticancer Res. 34(9):5205-10, 2014.[Pubmed]

Suzuki G, Yamazaki H, Ogo E, Abe T, Eto H, Muraki K, Hattori C, Umeno H, Nakashima T, Tanaka T, Nakamura S, Yoshida K. Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy. Anticancer Res. 34(4):1989-92, 2014.[Pubmed]

Suzuki G, Yamazaki H, Ogo E, Abe T, Hayabuchi N, Umeno H, Nakashima T, Nakamura S, Yoshida K. Multimodal treatment for t1-2 supraglottic cancer: the impact of tumor location. Anticancer Res. 34(1):203-7, 2014.[Pubmed]

Suzuki O., Mitsuyoshi T., Miyazaki M., Teshima T., Nishiyama K., Ubbels JF., Bolt RA., Langendijk JA., Widder J. Dose-volume-response analysis in stereotactic radiotherapy for early lung cancer. Radiother. Oncol. 112(2): 262-6, 2014.[Pubmed]

Takeda Y, Nakamori S, Eguchi H, Kobayashi S, Marubashi S, Tanemura M, Konishi K, Yoshioka Y, Umeshita K, Mori M, Doki Y, Nagano H. Neoadjuvant gemcitabine-based accelerated hyperfractionation chemoradiotherapy for patients with borderline resectable pancreatic adenocarcinoma. Jpn J Clin Oncol. 44:1172-80, 2014.[Pubmed]

Tamari K, Hayashi K, Ishii H, Kano Y, Konno M, Kawamoto K, Nishida N, Koseki J, Fukusumi T, Hasegawa S, Ogawa H, Hamabe A, Miyo M, Noguchi K, Seo Y, Doki Y, Mori M, Ogawa K.. Identification of chemoradiation-resistant osteosarcoma stem cells using an imaging system for proteasome activity. Int J Oncol. 45(6):2349-54,2014.[Pubmed]

Tamari K, Suzuki O, Hashimoto N, Kagawa N, Fujiwara M, Seo Y, Isohashi F, Yoshioka Y, Yoshimine T, Ogawa K.. Treatment Outcomes using CyberKnife for brain metastases from lung cancer. J Radiat Res. 56(1):151-8,2015.[Pubmed]

Tamari K, Ishohashi F, Akino Y, Suzuki O, Seo Y, Yoshioka Y, Hayashi Y, Nishida T, Takehara T, Mori M, Doki Y, Ogawa K.. Impact of Clinical and Dosimetric Factors on Pericardial Effusion in Patients with Stage I Esophageal Cancer Treated with Definitive Chemoradiotherapy. Anticancer Res. 34(12):7389-93,2014.[Pubmed]

Tamiya A, Matsumura A, Tsuji T, Morimoto M, Asami K, Okishio K, Shimizu S, Yoon HE, Atagi S, Akira M, Kitaichi M, Kawaguchi T. A pilot study of cisplatin and etoposide with and without radiotherapy for advanced malignant thymoma. Anticancer Res. 34(4):2023-7, 2014.[Pubmed]

Tomita N, Kodaira T, Teshima T, Ogawa K, Kumazaki Y, Yamauchi C, Toita T, Uno T, Sumi M, Onishi H, Kenjo M,, Nakamura K. Japanese Structure Survey of High-Precision Radiotherapy in 2012 Based on Institutional Questionnaire about the Patterns of Care. Jpn J Clin Oncol. 44(6):579-86,2014.[Pubmed]

Uchiyama Y, Matsumoto K, Murakami S, Kanesaki T, Matsumoto A, Kishino M, Furukawa S. [2014] MRI in a case of osteosarcoma in the temporomandibular joint.Dentomaxillofac Radiol.43(2):20130280, 2014.[Pubmed]

Usmani MN, Masai N, Oh RJ, Shiomi H, Tatsumi D, Miura H, Inoue T, Koizumi M. Comparison of Absorbed Dose to Medium and Absorbed Dose to Water for Spine IMRT Plans Using a Commercial Monte Carlo Treatment Planning System. IJMPCERO. 3(1): 60-6, 2014

Usmani MN, Takegawa H, TakashinaM, Numasaki H, Suga M, Anetai Y, Kurosu K, Koizumi M, Teshima T. Development and reproducibility evaluation of a MonteCarlo-based standard LINAC model for quality assurance of multi-institutional clinical trials. J. Radiat. Res. 55(6): 1131-40, 2014.[Pubmed]

Yagi M, Arentesen L, Shanley RM, Rosen CJ, Kidder LS, Sharkey LC, Yee D, Ogawa K, Hui S.,A Dual Isotope Hybrid Whole Body Micro-PET/CT System Reveals Functional Heterogeneity and Early Local and Systemic Changes Following Targeted Radiation to the Murine Caudal Skeleton. Calcif Tissue Int. 14(5):173-86,2014.[Pubmed]

Yamada S, Ueguchi T, Ogata T, Mizuno H, Ogihara R, Koizumi M, Shimazu T, Murase K, Ogawa K.. Radiotherapy treatment planning with contrast-enhanced computed tomography: feasibility of dual-energy virtual unenhanced imaging for improved dose calculations. Radiat Oncol. 29;9:168,2014.[Pubmed]

Yamazaki H, Ogita M, Himei K, Nakamura S, Yoshida K, Kotsuma T, Yamada Y, Fujiwara M, Baek S, Yoshioka Y. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume. Anticancer Res. 34(10):5755-9, 2014.[Pubmed]

Yamazaki H, Nakamura S, Nishimura T, Yoshida K, Yoshioka Y, Koizumi M, Ogawa K. Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis. J Radiat Res. 55(6): 1033-47, 2014.[Pubmed]

Yashiro K, Iwata A, Takada K, Murakami S, Uchiyama Y, Furukawa S. Temporomandibular joint articulations on working side during chewing in adult females with cross-bite and mandibular asymmetry.J Oral Rehabil,42(3):163-72.2015

Yashiro K, Murakami S, Uchiyama Y, Furukawa S. Validity of New Jerk-based Measurement to Evaluate Instability of Condylar Movements due to Occlusal Interference/Joint Deformation. Advanced Biomedical Engineering.3: 44-49, 2014

Yashiro K, Yamamoto K, Takada K, Murakami S, Uchiyama Y, Furukawa S. Influence of balancing-side occlusal interference on smoothness of working-side condylar movement and intra-articular space in chewing efforts.J Oral Rehabil.42(1):10-7, 2014.[Pubmed]

Yogi A, Koga T, Azama K, Higa D, Ogawa K, Watanabe T, Ishiuchi S, Murayama S. Usefulness of the apparent diffusion coefficient (ADC) for predicting the consistency of intracranial meningiomas. Clin Imaging. 38(6):802-7,2014.[Pubmed]

Yoshida H, Oshiro N, Fukuda A, Gamoh S, Shimizutani K, Morita S. A case of reformed coronoid process and mandibular angle after coronoidectomy and anglectomy for masticatory muscle tendon-aponeurosis hyperplasia. Oral Radiology, 30 : 129-133, 2014

Yoshida H, Matsusita T, Oshiro N, Yamamoto S, Kobayashi N, Yasuda N, Takeyama A, Tsuji K, Shimizutani K and Morita S. A preliminary report on MRI findings one hour after autologous blood injection around the temporomandibular joint Capsule for habitual temporomandibular ioint dislocation.Journal of Osaka Dental University. 48(2):103-106, 2014

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Akiyama H, Tanaka E, Narumi Y, Yoshioka Y. Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer. Anticancer Res. 34:4433-8, 2014.[Pubmed]

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Akiyama H, Tanaka E, Yoshioka Y. Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy. Anticancer Res. 34:3077-81, 2014.[Pubmed]

Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Yoshida M, Masui K, Yoshioka Y, Narumi Y, Oka T, Tanaka E. High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer: are high-risk patients good candidates? Strahlenther Onkol 190:1015-20, 2014.[Pubmed]

Yoshida K, Yamazaki H, Nakamara S, Masui K, Kotsuma T, Akiyama H, Tanaka E, Yoshioka Y. Comparison of common terminology criteria for adverse events v3.0 and radiation therapy oncology group toxicity score system after high-dose-rate interstitial brachytherapy as monotherapy for prostate cancer. Anticancer Res 34:2015-8, 2014.[Pubmed]

Yoshida K, Takenaka T, Akiyama H, Yamazaki H, Yoshida M, Masui K, Kotsuma T, Baek S, Uesugi Y, Shimbo T, Yoshikawa N, Arika T, Koretsune Y, Yoshioka Y, Narumi Y, Tanaka E. Three-dimensional image-based high-dose-rate interstitial brachytherapy for mobile tongue cancer. J Radiat Res. 55:154-61, 2014.[Pubmed]

Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y. Impact of intraluminal brachytherapy on survival outcome for radiotherapy for unresectable biliary tract cancer: A propensity score-matched pair analysis. Int J Radiat Oncol Biol Phys. 89(4): 822-9,2014.[Pubmed]

Yoshioka Y, Suzuki O, Otani Y, Yosha K, Nose T, Ogawa K. High-dose-rate brachytherapy as monotherapy for prostate cancer: Technique, rationale and erspective. J Contemp Brachytherapy. 6(1):91-8,2014.[Pubmed]

Yoshioka Y, Ogawa K, , Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Hatano K, Yoshimura M, Yamada K, Tokumaru S, Sekiguchi K, Kobayashi M, Soejima T, Isohashi F, Nemoto K, Nishimura Y. Factors Infncing Survival Outcome in Radiotherapy for Biliary Tract Cancer: A RetrospectiveSurvey Study in Japan. Radiother Oncol. 110(3):546-52,2014.[Pubmed]

Yoshioka Y, Konishi K, Suzuki O, Nakai Y, Isohashi F, Seo Y, Otani Y, Koizumi M, Yoshida K, Yamazaki H, Nonomura N, Ogawa K. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: a dose reduction trial. Radiother Oncol.110(1):114-9, 2014.[Pubmed]

2013

Akino Y, Yoshioka Y, Fukuda S, Maruoka S, Takahashi Y, Yagi M, Mizuno H, Isohashi F, Ogawa K: Estimation of Rectal Dose Using Daily Megavoltage Cone-beam Computed Tomography and Deformable Image Registration. Int J Radiat Oncol Biol Phys 87(3): 602-608, 2013. [Pubmed]

Akino Y, Ota S, Inoue S, Mizuno H, Sumida I, Yoshioka Y, Isohashi F, Ogawa K: Characteristics of flattening filter free beams at low monitor unit settings. Med Phys 40: 112101, 2013. [Pubmed]

Deng Z, Hasegawa M, Kiyuna A, Matayoshi S, Uehara T, Agena S, Yamashita Y, Ogawa K, Maeda H, Suzuki M: Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.Head Neck. 35(6):800-8, 2013. [Pubmed]

Hiraki M, Nishimura J, Ohtsuka M, Shiomi H, Uemura M, Haraguchi N, Hata T, Hayashi T, Takemasa I, Mizushima T, Isohashi F, Yoshioka Y, Ogawa K, Doki Y, Mori M, Yamamoto H: Impact of stereotactic body radiotherapy on colorectal cancer with distant metastases.Oncol Rep. [E-pub ahead of print]. [Pubmed]

Inoue T, Oh RJ, Shiomi H, Masai N, Miura H: Stereotactic body radiotherapy for pulmonary metastases. Prognostic factors and adverse respiratory events.Strahlenther Onkol. 189(4):285-92, 2013. [Pubmed]

Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, Ogata T, Maruoka S, Kimura T, Ogawa K. Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiotherapy for early-stage cervical cancer. Int J Radiat Oncol Biol Phys. 85:728-734, 2013. [Pubmed]

Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y. Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey. Radiat Oncol, 8:76, 2013. [Pubmed]

Iwama K, Yamazaki H, Nishimura T, Oota Y, Aibe H, Nakamura S, Ikeno H, Yoshida K, Okabe H. Analysis of intrafractional organ motion for patients with prostate cancer using soft tissue matching image-guided intensity-modulated radiation therapy by helical tomotherapy. Anticancer Res. 33(12):5675-9, 2013. [Pubmed]

Kakimoto N, Chindasombatjaroen J, Tomita S, Shimamoto H, Uchiyama Y, Hasegawa Y, Kishino M, Murakami S, Furukawa S. Contrast-enhanced multidetector computerized tomography for odontogenic cysts and cystic-appearing tumors of the jaws: is it useful? Oral Surg Oral Med Oral Pathol Oral Radiol. 115: 104-13, 2013. [Pubmed]

Kano Y, Konno M, Kawamoto M, Tamari K, Hayashi K, Fukusumi T, Satoh T, Tanaka S, Ogawa K, Mori M, Doki Y, Ishii H. Novel drug discovery system for cancer stem cells in human squamous cell carcinoma of the esophagus. Oncology Reports. [E-pub ahead of print] [Pubmed]

Kasuya G, Ogawa K, Iraha S, Nagai Y, Hirakawa M, Toita T, Kakinohana Y, Kudaka W, Inamine M, Ariga T, Aoki Y, Murayama S. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival. Anticancer Res. 33(5):2199-204, 2013 [Pubmed]

Kobayashi K, Okihara K, Iwata T, Aibe N, Kodani N, Tsubokura T, Kamoi K, Miki T, Yamazaki H. Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience. J Radiat Res. 54(3):479-84, 2013 [Pubmed]

Kohshi K, Beppu T, Tanaka K, Ogawa K, Inoue O, Kukita I, Clarke RE. Potential roles of hyperbaric oxygenation in the treatments of brain tumors. Undersea Hyperb Med. 40(4):351-62, 2013 [Pubmed]

Mabuchi S, Takahashi R, Isohashi F, Yokoi T, Ito K, Tsutui T, Ogata T, Yoshioka Y, Ogawa K, Kimura T. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes. Int J Gynecol Cancer. 23:1279-86, 2013 [Pubmed]

Matsuo K, Mabuchi S, Okazawa M, Matsumoto Y, Tsutsui T, Fujita M, Kamiura S, Ogawa K, Morrow CP, Kimura T. Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer. Br J Cancer, 108(6):1348-57, 2013 [Pubmed]

Miura H, Masai N, Oh RJ, Shiomi H, Sasaki J, Inoue T. Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion. J Radiat Res. 54(1):140-5, 2013 [Pubmed]

Morimoto M, Yoshioka Y, Kotsuma T, Adachi K, Shiomi H, Suzuki O, Seo Y, Koizumi M, Kagawa N, Kinoshita M, Hashimoto N, Ogawa K. Hypofractionated stereotactic radiation therapy in three to five fractions for vestibular schwannoma. Jpn J Clin Oncol. 43:805-12, 2013 [Pubmed]

Morimoto M, Isohashi F, Yoshioka Y, Suzuki O, Seo Y, Ogata T, Akino Y, Koizumi M, Ogawa K. Salvage high-dose-rate interstitial brachytherapy for locallyrecurrent rectal cancer: long-term follow-up results. Int J Clin Oncol. [Epub ahead of print] [Pubmed]

Nishimura T, Yamazaki H, Aibe N, Nakamura S, Yoshida K, Okabe H. Exceptionally high incidence of grade 2-3 late rectal toxicity in patients with prostate cancer receiving hypofractionated (2.2 Gy) soft tissue-matched image-guided intensity-modulated radiotherapy. Anticancer Res. 33(12):5507-10, 2013 [Pubmed]

Nishimura T, Yamazaki H, Iwama K, Kotani T, Oota Y, Aibe H, Nakamura S, Ikeno H, Yoshida K, Isohashi F, Okabe H.Assessment of planning target volume margin for a small number of vertebral metastatic lesions using image-guided intensity-modulated radiation therapy by helical tomotherapy. Anticancer Res. 33(6):2453-6, 2013 [Pubmed]

Numasaki H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Nishimura T, Murakami M, Takahashi M, Teshima T and JASTRO Database Committee. Japanese structure survey of radiation oncology in 2009 with special reference to designated cancer care hospitals. Int J Clin Oncol. 18:775-83, 2013 [Pubmed]

Ogata T, Ueguchi T, Yagi M, Yamada S, Tanaka C, Ogihara R, Isohashi F, Yoshioka Y, Tomiyama N, Ogawa K, Koizumi M. Feasibility and accuracy of relative electron density determined by virtual monochromatic CT value subtraction at two different energies using the gemstone spectral imaging. Radiat Oncol. 8:83, 2013 [Pubmed]

Ogawa K, Kohshi K, Ishiuchi S, Matsushita M, Yoshimi N, Murayama S. Old but new methods in radiation oncology: Hyperbaric oxygen therapy. Int J Clin Oncol. 18(3):364-70, 2013 [Pubmed]

Ogawa K, Yoshioka Y, Isohashi F, Seo Y, Yoshida K, Yamazaki H. Radiotherapy targeting cancer stem cells: current views and future perspectives. Anticancer Res. 33(3):747-754, 2013 [Pubmed]

Okahata R, Shimamoto H, Marutani K, Tomita S, Nakatani A, Kishino M, Kakimoto N, Murakami S, Furukawa S. Diffuse large B-cell lymphoma of the mandible with periosteal reaction: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 117: e228-32, 2013 [Pubmed]

Okami J, Nishiyama K, Fujiwara A, Konishi K, Kanou T, Tokunaga T, Teshima T, Higashiyama M. Radiotherapy for postoperative thoracic lymph node recurrence of non-small-cell lung cancer provides better outcomes if the disease is asymptomatic and a single-station involvement. J Thorac Oncol. 8(11): 1417-24, 2013 [Pubmed]

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T. Impact of the Addition of Concurrent Chemotherapy to Pelvic Radiotherapy in Surgically Treated Stage IB1-IIB Cervical Cancer Patients With Intermediate-Risk or High-Risk Factors: A 13-Year Experience. Int J Gynecol Cancer. 23(3):567-75, 2013 [Pubmed]

Shibamoto Y, Sumi M, Onodera S, Matsushita H, Sugie C, Tamaki Y, Onishi H, Abe E, Koizumi M, Miyawaki D, Kubota S, Ogo E, Nomiya T, Takemoto M, Harada H, Takahashi I, Ohmori Y, Ishibashi N, Tokumaru S, Suzuki K. Primary CNS lymphoma treated with radiotherapy in Japan: a survey of patients treated in 2005-2009 and a comparison with those treated in 1985-2004. Int J Clin Oncol. [Epub ahead of print] [Pubmed]

Sumida I, Yamaguchi H, Kizaki H, Yamada Y, Koizumi M, Yoshioka Y, Ogawa K, Kakimoto N, Murakami S, Furukawa S. Evaluation of imaging performance for megavoltage cone-beam CT over an extended period. J Radiat Res. [E-pub ahead of print] [Pubmed]

Suzuki G, Ogo E, Abe T, Hayabuchi N, Umeno H, Nakashima T, Yamazaki H, Nakamura S, Yoshida K. Non-surgical multimodality treatment for locally advanced (T3-4) hypopharyngeal cancer: the impact of pre-treatment hemoglobin level. Anticancer Res. 33(12):5561-5, 2013 [Pubmed]

Taguchi A, Akiyama H, Koseki T, Shimizutani K. Recognition of bisphosphonate-related osteonecrosis of the jaw among oral and maxillofacial radiologists: results from a questionnaire-based survey in Japan. Oral Radiol [E-pub ahead of print]

Takakura T., Nakamura M., Shibuya K., Nakata M., Nakamura A., Matsuo Y., Shiinoki T., Higashimaura K., Teshima T., Hiraoka M. Effects of interportal error on dose distribution in patients undergoing breath-holding intensity-modulated radiotherapy for pancreatic cancer: evaluation of a new treatment planning method. J. Appl. Med. Phys. 14(5): 43-51, 2013 [Pubmed]

Toyosawa S, Murakami S ,Kishino M, Kogo M. A brief review: characteristics of bisphosphonate-related osteonecrosis of the jaw (BRONJ) from the viewpoint of pathology. Oral Radiol. 29: 105-110, 2013

Uchiyama Y, Murakami S, Kishino M, Furukawa S. CT and MR imaging features of a case of calcifying epithelial odontogenic tumor. JBR-BTR. 95: 315-9, 2013 [Pubmed]

Uchiyama Y, Murakami S, Furukawa S. Temporomandibular joints in patients with rheumatoid arthritis using magnetic resonance imaging. Clin Rheumatol. 32: 1613-8, 2013 [Pubmed]

Wada H, Nemoto K, Nomiya T, Murakami M, Suzuki M, Kuroda Y, Ichikawa M, Ota I, Hagiwara Y, Ariga H, Takeda K, Takai K, Fujimoto K, Kenjo M, Ogawa K. A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrent rectal cancer. Int J Clin Oncol. 18(2):273-8, 2013 [Pubmed]

Yagi M, Ueguchi T, Koizumi M, Ogata T, Yamada S, Takahashi Y, Sumida I, Akino Y, Konishi K, Isohashi F, Tomiyama N, Yoshioka Y, Ogawa K. Gemstone spectral imaging: Determination of CT to ED conversion curves for radiotherapy treatment planning. J Appl Clin Med Phys. 14(5):4335,2013 [Pubmed]

Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa K. High dose rate brachytherapy for oral cancer. J Radiat Res. 54:1-1, 2013 [Pubmed]

Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa k. High dose rate brachytherapy for oral cancer. J Radiat Res. 54(1) : 1-17, 2013 [Pubmed]

Yamazaki H, Ogita M, Kodani N, Nakamura S, Inoue H, Himei K, Kotsuma T, Yoshida K, Yoshioka Y, Yamashita K, Udono H. Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: A multi-institutional study. Radiother Oncol. 107:305-9, 2013 [Pubmed]

Yamazaki H, Nakamura S, Nishimura T, Kodani N, Tsubokura T, Kimoto T, Sihomi H, Aibe N, Yoshida K, Koizumi M, Kagiya T. Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report. Anticancer Res. 33(4):1773-6, 2013 [Pubmed]

Yamazaki H, Nakamura S, Nishimura T, Okabe H, Aibe N, Yoshida K, Kagiya T. Intensity-modulated radiation therapy with hypoxic sensitizer AK-2123 (sanazole) for glioblastoma multiforme using simultaneous integrated boost technique. Anticancer Res. 33(4):1685-8, 2013 [Pubmed]

Yamazaki H, Iwama K, Nishimura T, Iwai Y, Aibe N, Takenaka T, Miyake S, Tanaka E, Yoshida K, Oota Y, Ikeno H, Nakamura S, Okabe H. Comparison of calculated dose by helical tomotherapy treatment planning machine and measured dose of radiophotoluminescence glass dosimeter in lung lesions using Rando Phantom. Anticancer Res. 33(4):1679-84, 2013 [Pubmed]

Yamazaki H, Nakamura S, Kobayashi K, Tsubokura T, Kodani N, Aibe N, Yoshida K, Kagiya T, Koizumi M, Yamada K. Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapy. Anticancer Res. 33(2):643-6, 2013 [Pubmed]

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Baek SJ, Akiyama H, Tanaka E, Yoshioka Y. Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients with gynecological cancer: speculation on the relation between pallor reaction and stenosis. Anticancer Res. 33:3963-8, 2013 [Pubmed]

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Akiyama H, Tanaka E, Yoshioka Y. Re-irradiation using interstitial brachytherapy increases vaginal mucosal reaction compared to initial brachytherapy in patients with gynecological cancer. Anticancer Res. 33:5687-92, 2013 [Pubmed]

Yoshida K, Yamazaki H, Nakamura S, Masui K, Kotsuma T, Baek SJ, Akiyama H, Tanaka E, Yoshioka Y. Comparisons of late vaginal mucosal reactions between interstitial and conventional intracavitary brachytherapy in patients withgynecological cancer: speculation on the relation between pallor reaction andstenosis. Anticancer Res. 33:3963-8, 2013 [Pubmed]

Yoshioka Y, Yoshida K, Yamazaki H, Nonomura N, Ogawa K. The emerging role of high-dose-rate (HDR) brachytherapy as monotherapy for prostate cancer. J Radiat Res. 54:781-8, 2013 [Pubmed]

Yoshioka Y, Konishi K, Suzuki O, Nakai Y, Isohashi F, Seo Y, Otani Y, Koizumi M, Yoshida K, Yamazaki H, Nonomura N, Ogawa K. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: A dose reduction trial. Radiother Oncol [Epub ahead of print] [Pubmed]

Yoshioka Y, Suzuki O, Nishimura K, Inoue H, Hara T, Yoshida K, Imai A, Tsujimura A, Nonomura N, Ogawa K. Analysis of late toxicity associated withexternal beam radiation therapy for prostate cancer with uniform setting ofclassical 4-field 70 Gy in 35 fractions: a survey study by the Osaka Urological Tumor Radiotherapy Study Group. J Radiat Res. 54:113-25, 2013 [Pubmed]

2012

Akino Y, Koizumi M, Sumida I, Takahashi Y, Ogata T, Ota S, Isohashi F, Konishi K, Yoshioka Y: Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 82: 1715-1722, 2012. [Pubmed]

Akiyama H, Yoshida K, Shimizutani K, Yamazaki H, Koizumi M, Yoshioka Y, Kakimoto N, Murakami S, Furukawa S, Ogawa K: Dose reduction trial from 60 Gy in 10 fractions to 54 Gy in 9 fractions schedule in high-dose-rate interstitial brachytherapy for early oral tongue cancer. J Radiat Res 53: 722-726, 2012. [Pubmed]

Ariga T, Ogawa K, Shimoji H, Karimata H, Toita T, Kakinohana Y, Kasuya G, Nishimaki T, Yoshimi N, Murayama S Radical radiotherapy for superficial esophageal cancer: impact of clinical N stage on survival. Anticancer Res 32(8): 3371-6, 2012. [Pubmed]

Deng Z, Hasegawa M, Kiyuna A, Matayoshi S, Uehara T, Agena S, Yamashita Y, Ogawa K, Maeda H, Suzuki M. Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma. Head Neck. 2012 Jul 13. doi: 10.1002/hed.23034. [Epub ahead of print] . [Pubmed]

Iraha Y, Murayama S, Kamiya A, Iraha S, Ogawa K. Diffusion-weighted MRI and PSA Correlations in Patients with Prostate Cancer Treated with Radiation and Hormonal Therapy. Anticancer Res 32(10): 4467-71, 2012. [Pubmed]

Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, Ogata T, Maruoka S, Kimura T, Ogawa K: Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiotherapy for early-stage cervical cancer. Int J Radiat Oncol Biol Phys 2012 Epub ahead of print. [Pubmed]

Kakimoto N, Murakami S, Nakatani A, Yoshioka Y, Shimizutani K, Furukawa S: Electron beam radiotherapy for tongue cancer using an intra-oral cone. Oral Oncol 48: 463-468, 2012. [Pubmed]

Koizumi M, Tanjung NG, Chen A, Dynlacht JR, Garrett J, Yoshioka Y, Ogawa K, Teshima T, Yokota H: Administration of salubrinal enhances radiation-induced cell death of SW1353 chondrosarcoma cells. Anticancer Res 32: 3667-3673, 2012. [Pubmed]

Mabuchi S, Isohashi F, Maruoka S, Hisamatsu T, Takiuchi T, Yoshioka Y, Kimura T: Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy. Arch Gynecol Obstet 286: 179-185, 2012. [Pubmed]

Mabuchi S, Okazawa M, Kinose Y, Matsuo K, Fujiwara M, Suzuki O, Morii E, Kamiura S, Ogawa K, Kimura T. Comparison of the Prognoses of FIGO Stage I to Stage II Adenosquamous Carcinoma and Adenocarcinoma of the Uterine Cervix Treated With Radical Hysterectomy. Int J Gynecol Cancer 22(8): 1389-1397, 2012. [Pubmed]

Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, Enomoto T, Kamiura S, Ogawa K, Kimura T. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol. 2012 Oct;127(1):114-20. doi: 10.1016/j.ygyno.2012.06.021. Epub 2012 Jun 21. . [Pubmed]

Miura H, Masai N, Oh R-J, Shiomi H, Sasaki J, Inoue T:Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion. J Radiat Research. doi:10.1093/jrr/rrs054 Advanced Access Publication, September 5, 2012. [Pubmed]

Mizuno H., Takahashi Y., Tanaka A., Hirayama T., Yamaguchi T., Katou H., Takahara K., Okamoto Y., Teshima T. Homogeneity of GAFCHROMIC EBT2 film among different lot numbers. J. Appl. Clin. Med. Phys. 13 (4): 3763, 2012. . [Pubmed]

Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T, Tamamoto T.  Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey. Int J Clin Oncol 17(1):48-54 2012. [Pubmed]

Numasaki H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Murakami M, Takahashi M, Nishimura T, Teshima T; Japanese Society for Therapeutic Radiology and Oncology Database Committee. Japanese structure survey of radiation oncology in 2009 with special reference to designated cancer care hospitals. Int. J. Clin. Cncol. 17 (1), 2012 (in press). [Pubmed]

Numasaki H., Shibuya H., Nishio M., Ikeda H., Sekiguchi K., Kamikonya N., Koizumi M., Tago M., Ando Y., Tsukamoto N., Terahara A., Nakamura K., Mitsumori M., Nishimura T., Hareyama M., Teshima T., and Japanese Society of Therapeutic Radiology and Oncology Database Committee. National Medical Care System may impede fostering of true specialization of radiation oncologists: Study based on structure survey in Japan. Int. J. Radiat. Oncol. Biol. Phys. 82 (1): e111-e117, 2012. [Pubmed]

Ogata T., Yamazaki H., Teshima T., Tsuchiya T., Nishimoto N., Matsuura N. Anti-IL-6 receptor antibody does not ameliorate radiation pneumonia in mice. Exp. Ther. Med. 4 (2): 273-276, 2012. [Pubmed]

Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, Fujita J, Uezato H, Murayama S. Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients. Br J Radiol. 2012 Nov;85(1019):e1127-33. doi: 10.1259/bjr/31655219. Epub 2012 Jul 17. [Pubmed]

Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H, Saito T, Onishi H, Karasawa K, Nemoto K, Nishimura Y; Japanese Radiation Oncology Study Group Working Subgroup of Gastrointestinal Cancers.  Concurrent radiotherapy and gemcitabine for unresectable pancreatic adenocarcinoma: impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys. 83(2): 559-65, 2012. Epub 2011 Oct 20. [Pubmed]

Ogawa K, Ishiuchi S, Inoue O, Yoshii Y, Saito A, Watanabe T, Iraha S, Toita T, Kakinohana Y, Ariga T, Kasuya G, Murayama S.  Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results. Int J Radiat Oncol Biol Phys. 82(2): 732-8, 2012. Epub 2011 Mar 21. [Pubmed]

Okamoto T, Akiyama H, Gamoh S, Shimizutani K. High-dose-rate interstitial brachytherapy for tongue cancer; a radiological and biological study from the perspective of late complications. J Osaka Dent Univ 46(1): 57-62, 2012.

Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Sano N, Oguri M, Onohara K, Watanabe I, Koshiishi T, Ogawa K, Araki T. Large prostate motion produced by anal contraction. Radiother Oncol. 104(3): 390-4, 2012. doi: 10.1016/j.radonc.2012.04.005. Epub 2012 Jun 5. [Pubmed]

Yuki Otani, Takahiro Yamada, Shingo Kato, Naoto Shikama, Kazuto Funakoshi, Isao Kuroda, Hodaka Numasaki, Takayuki Nose, Takushi Dokiya, Masahiko Oguchi, "Source strength assay of iodine-125 seeds sealed within sterile packaging" J Appl Clin Med Phys. (in press). [Pubmed]

Ozawa S., Tachimori Y., Baba H., Fujishiro M., Matsubara H., Numazaki H., Oyama T., Shinoda M., Takeuchi H., Teshima T., Udagawa H., Uno T., Barron J.P., Comprehensive Registry of Esophageal Cancer in Japan, 2004. Esophagus 9: 75-98, 2012.

Ozawa S., Tachimori Y., Baba H., Fujishiro M., Matsubara H., Numazaki H., Oyama T., Shinoda M., Takeuchi H., Teshima T., Udagawa H., Uno T., Barron J.P., The Registration Committee for Esophageal Cancer.: Comprehensive Registry of Esophageal Cancer in Japan, 2004. The Japan Esophageal Society (Chiba), March 2012.

Sumida I, Yamaguchi H, Kizaki H, Koizumi M, Ogata T, Takahashi Y, Yoshioka Y: Quality assurance of MLC leaf position accuracy and relative dose effect at the MLC abutment region using an electronic portal imaging device. J Radiat Res 53: 798-806, 2012. [Pubmed]

Takahashi Y, Koizumi M, Sumida I, Isohashi F, Ogata T, Akino Y, Yoshioka Y, Maruoka S, Inoue S, Konishi K, Ogawa K: The usefulness of independent patient-specific treatment planning verification method using a benchmark plan in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix. J Radiat Res 53: 936-944, 2012. [Pubmed]

Takenaka T, Yoshida K, Tachiiri S, Yamazaki H, Aramoto K, Furuya S, Yoshida M, Ban C, Tanaka E, Honda K. Comparison of dose-volume analysis between standard Manchester plan and magnetic resonance image-based plan of intracavitary brachytherapy for uterine cervical cancer. J Radiat Res 53(5):791-7, 2012. [Pubmed]

Takenaka T, Yoshida K, Ueda M, Yamazaki H, Miyake S, Tanaka E, Yoshida M, Yoshimura Y, Oka T, Honda K. Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations. J Radiat Res 53(3): 469-74, 2012. [Pubmed]

Teshima T., Numasaki H., Nishio M., Ikeda H., Sekiguchi K., Kamikonya N., Koizumi M., Tago M., Ando Y., Tsukamoto N., Terahara A., Nakamura K., Murakami M., Takahashi M., Nishimura T.; Japanese Society for Therapeutic Radiology and Oncology Database Committee. Japanese structure survey of radiation oncology in 2009 based on institutional stratification of the Patterns of Care Study. J. Radiat. Res. 53 (5): 710-21, 2012. [Pubmed]

Toita T., Kato S., Niibe Y., Ohno T., Kazumoto T., Kodaira T., Kataoka M., Shikama N., Kenjo M., Tokumaru S., Yamauchi C., Suzuki O., Sakurai H., Numasaki H., Teshima T., Oguchi M., Kagami Y., Nakano T., Hiraoka M., Mitsuhashi N. Prospective multi-institutional study of definitive radiotherapy with high-dose rate intracavitary brachytherapy in patients with non-bulky (< 4 cm) stage I, II uterine cervical cancer (JAROG0401/JROSG04-2). Int. J. Radiat. Oncol. Biol. Phys. 82 (1): e49-e56, 2012. [Pubmed]

Tokumaru S., Toita T., Oguchi M., Ohno T., Kato S., Niibe Y., Kazumoto T., Kodaira T., Kataoka M., Shikama N., Kenjo M., Yamauchi C., Suzuki O., Sakurai H., Teshima T., Kagami Y., Nakano T., Hiraoka M., Mitsuhashi N., Kudo S. Insufficiency fractures after pelvic radiation therapy for uterine cervical cancer: An analysis of subjects in a prospective multi-institutional trial, and cooperative study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG). Int. J. Radiat. Oncol. Biol. Phys. 84 (2): e195-e200, 2012. [Pubmed]

Tomita N., Toita T., Kodaira T., Shinoda A., Uno T., Numasaki H., Teshima T., Mitsumori M. Patterns of radiotherapy practice for patients with cervical cancer in Japan, 2003-2005: Changing trends in the Patterns of Care Process. Int. J. Radiat. Oncol. Biol. Phys. 83 (5): 1506-1513, 2012. [Pubmed]

Uchiyama Y, Akiyama H, Murakami S, Koseki T, Kishino M, Fukuda Y, Shimizutani K, Furukawa S. Calcifying cystic odontogenic tumour: CT imaging. Br J Radiol 85 (1013): 548-554, 2012. [Pubmed]

Wada H, Nemoto K, Nomiya T, Murakami M, Suzuki M, Kuroda Y, Ichikawa M, Ota I, Hagiwara Y, Ariga H, Takeda K, Takai K, Fujimoto K, Kenjo M, Ogawa K. A phase I trial of S-1 with concurrent radiotherapy in patients with locally recurrent rectal cancer. Int J Clin Oncol. 2012 Feb 9. [Epub ahead of print]. [Pubmed]

Yamashiro T, Kamiya H, Miyara T, Gibo S, Ogawa K, Akamine T, Moromizato H, Yara S, Murayama S.  CT scans of the chest in carriers of human T-cell lymphotropic virus type 1: presence of interstitial pneumonia. Acad Radiol. 19(8): 952-7, 2012. Epub 2012 May 10. [Pubmed]

Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa K. High dose rate brachytherapy for oral cancer. J Radiat Res 54(1):1-17, 2013. [Pubmed]

Yamazaki H, Yoshida K, Kobayashi K, Tsubokura T, Kodani N, Aibe N, Ikeno H, Nishimura T. Assessment of radiation dermatitis using objective analysis for patients with breast cancer treated with breast-conserving therapy: influence of body weight. Jpn J Radiol. 30(6): 486-91, 2012. [Pubmed]

Yoshida K, Ueda M, Takenaka T, Yamazaki H, Kotsuma T, Aramoto K, Miyake S, Koretsune Y, Ban C, Tanaka E. Daily CT measurement of needle applicator displacement during multifractionated high-dose-rate interstitial brachytherapy for postoperative recurrent uterine cancer. J Radiat Res 53(2): 295-300, 2012. [Pubmed]

Yoshida K, Ueda M, Yamazaki H, Takenaka T, Yoshida M, Miyake S, Yoshida S, Koizumi M, Ban C, Tanaka E. Interstitial brachytherapy using virtual planning and Doppler transrectal ultrasonography guidance for internal iliac lymph node metastasis. J Radiat Res 53(1): 154-8, 2012. [Pubmed]

Yoshioka Y, Suzuki O, Nishimura K, Inoue H, Hara T, Yoshida K, Imai A, Tsujimura A, Nonomura N, Ogawa K: Analysis of late toxicity associated with external beam radiation therapy for prostate cancer with uniform setting of classical 4-field 70 Gy in 35 fractions: A survey study by the Osaka Urological Tumor Radiotherapy Study Group. J Radiat Res 54(1): 113-25, 2013. [Pubmed]

Yamazaki H, Yoshida K, Yoshioka Y, Shimizutani K, Furukawa S, Koizumi M, Ogawa K. High dose rate brachytherapy for oral cancer. J Radiat Res 2012 Epub ahead of print. [Pubmed]

2011

Akino Y, Koizumi M, Sumida I, Takahashi Y, Ogata T, Ota S, Isohashi F, Konishi K, Yoshioka Y. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 82(5): 1715-22, 2011. [Pubmed]

Akino Y, Koizumi M, Sumida I, Takahashi Y, Ogata T, Ota S, Isohashi F, Konishi K, Yoshioka Y. Megavoltage cone beam computed tomography dose and the necessity of reoptimization for imaging dose-integrated intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 82(5): 1715-22, 2011. [Pubmed]

Chiba I, Ogawa K, Morioka T, Shimoji H, Sunagawa N, Iraha S, Nishimaki T, Yoshimi N, MurayamaS. Clinical Significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Oncol Lett 2(1): 21-28, 2011. [Pubmed]

Gamoh S, Akiyama H, Yotsui Y, Nakashima N, Koseki T, Sanuki T, Kotani J Shimizutani K. CT scans and MRI of a calcifying epithelial odontogenic tumor (Pindborg tumor). J Osaka Dent Univ. 45(2): 227-231, 2011. [CiNii]

Hirakawa M, Nagai Y, Toita T, Kudaka W, Inamine M, Ogawa K, Murayama S, Aoki Y. High-risk group for locoregional recurrence in patients with stage IB-IIB squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy. Anticancer Res. 31: 1347-1442, 2011. [Pubmed]

Iida G, Ogawa K, Ishiuchi S, Chiba I, Watanabe T, Katsuyama N, Yoshii Y, Murayama S. Clinical Significance of Thallium-201 SPECT after Postoperative Radiotherapy in Patients with Glioblastoma Multiforme. J Neurooncol. 103(2):297-305, 2011. [Pubmed]

Inoue T, Oh R-J, Shiomi H. New approach for treatment of vertebral metastases using intensity-modulated radiotherapy. Strahlenther Onkol. 187(2):108-113, 2011. [Pubmed]

Isohashi F, Konishi K, Umegaki N, Tanei T, Koizumi M, Yoshioka Y. A case of bullous pemphigoid exacerbated by irradiation after breast conservative radiotherapy. Jpn J Clin Oncol. 41(6):811-3, 2011. [Pubmed]

Kagara N, Nakano Y, Watanabe A, Inatome J, Nakamura H, Kim C, Danno K, Taniguchi H, Kanoh T, Kimura Y, Ohnishi T, Tono T, Monden T, Imaoka S, Kagawa K. Curative-intent stereotactic body radiation therapy for residual breast cancer liver metastasis after systemic chemotherapy. Breast Cancer. Jul 5, 2011[Epub ahead of print] [Pubmed]

Kasuya G, Ogawa K, Iraha S, Nagai Y, Shiraishi M, Hirakawa M, Samura H, Toita T, Kakinohana Y, Kudaka W, Inamine M, Ariga T, Nishimaki T, Aoki Y, Murayama S. Severe late complications in patients with uterine cancer treated with postoperative radiotherapy. Anticancer Res. 31(10):3527-33, 2011. [Pubmed]

Kawaguchi Y, Nishiyama K, Miyagi K, Suzuki O, Ito Y, Nakamura S. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer. Jpn J Clin Oncol. 41:1007-1012, 2011. [Pubmed]

Kodani N, Yamazaki H, Tsubokura T, Shiomi H, Kobayashi K, Nishimura T, Aibe N, Tsuda E, Nishimura T. Stereotactic body radiation therapy for head and neck tumor: Disease control and morbidity outcomes. J Radiat Res. 52: 24-31, 2011. [Pubmed]

Kotsuma T, Yoshida K, Yamazaki H, Takenaka T, Konishi K, Isohashi F, Koizumi M, Tanaka E, Yoshioka Y. Preliminary results of magnetic resonance imaging-aided high-dose-rate interstitial brachytherapy for recurrent uterine carcinoma after curative surgery. J Radiat Res. 52(3):329-34, 2011. [Pubmed]

Mabuchi S, Okazawa M, Isohashi F, Matsuo K, Ohta Y, Suzuki O, Yoshioka Y, Enomoto T, Kamiura S, Kimura T. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer. Gynecol Oncol. 123:241-247, 2011. [Pubmed]

Mabuchi S, Okazawa M, Isohashi F, Ohta Y, Maruoka S, Yoshioka Y, Enomoto T, Morishige K, Kamiura S, Kimura T. Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases. Gynecol Oncol. 120:94-100, 2011. [Pubmed]

Mabuchi S, Matsumoto Y, Isohashi F, Yoshioka Y, Ohashi H, Morii E, Hamasaki T, Aozasa K, Mutch DG, Kimura T. Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer. Gynecol Oncol. 122(1): 25-32, 2011. [Pubmed]

Mabuchi S, Okazawa M, Isohashi F, Matsuo K, Ohta Y, Suzuki O, Yoshioka Y, Enomoto T, Kamiura S, Kimura T. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer. Gynecol Oncol. 123(2): 241-247, 2011. [Pubmed]

Mikami M, Yoshida K, Takenaka T, Yamazaki H, Kotsuma T, Yoshida M, Aramoto K, Yamada S, Ban C, Tanaka E, Honda K. Daily computed tomography measurement of needle applicator displacement during high-dose-rate interstitial brachytherapy for previously untreated uterine cervical cancer. Brachytherapy. 10:318-324, 2011. [Pubmed]

Miyata H, Yamasaki M, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Morii E, Mori M, Doki Y. Prognostic Value of Endoscopic Biopsy Findings After Induction Chemoradiotherapy With and Without Surgery for Esophageal Cancer. Ann Surg. 253(2):279-84, 2011. [Pubmed]

Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Konishi K, Mori M, Doki Y. Survival Factors in Patients with Recurrecne After Curative Resection of Esophageal Squamous Cell Carcinomas. Ann Surg Oncol 18(12):3353-61, 2011. [Pubmed]

Miyara T, Oshiro Y, Yamashiro T, Kamiya H, Ogawa K, Murayama S. Bronchial diverticula detected by multidetector-row computed tomography: incidence and clinical features. J Thorac Imaging. 26(3):204-8, 2011. [Pubmed]

Miyazaki M, Suzuki O, Tsujii K, Ueda Y, Nishiyama K. Dosimetric Parameters of Simultaneous Integrated Boost IMRT with Sequential Boost for Head and Neck Cancer. Int J Radiat Oncol Biol Phys/ 81(2): S843, 2011.

Mori Y, Kakudo K, Gotoh M, Kubo H, Akiyama H, Yotsui Y, Shimizutani K. A case of synovial chondromatosis of the temporomandibular joint followed for 17 years. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 112(1) : e35-e39, 2011. [Pubmed]

Morimoto M, Yoshioka Y, Shiomi H, Isohashi F, Konishi K, Kotsuma T, Fukuda S, Kagawa N, Kinoshita M, Hashimoto N, Yoshimine T, Koizumi M. Significance of tumor volume related to peritumoral edema in intracranial meningioma treated with extreme hypofractionated stereotactic radiation therapy in three to five fractions. Jpn J Clin Oncol. 41(5):609-16, 2011. [Pubmed]

Nakajima A, Nishiyama K, Morimoto M, Nakamura S, Suzuki O, Kawaguchi Y, Miyagi K, Fujii T, Yoshino K. Definitive Radiotherapy for T1-2 Hypopharyngeal Cancer: A Single-Institution Experience. Int J Radiat Oncol Biol Phys. 82(2):e129-35, 2011. [Pubmed]

Nakashima R, Nishiyama K, Kawaguchi Y, Suzuki O, Nakamura S, Yoshino K. Definitive Radiotherapy for Supraglottic Laryngeal Carcinoma: A Single Institutional Experience. Int J Radiat Oncol Biol Phys 81(2): S518, 2011.

Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T, Tamamoto T. Clinical Practice and Outcome of Radiotherapy for Esophageal Cancer between 1999 and 2003: The Japanese Radiation Oncology Study Group (JROSG) Survey. Int J Clin Oncol, May 25, 2011[Epub ahead of print] [Pubmed]

Numasaki H, Shibuya H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Mitsumori M, Nishimura T, Hareyama M, Teshima T, Japanese Society of Therapeutic Radiology and Oncology Database Committee. National Medical Care System May Impede Fostering of True Specialization of Radiation Oncologists: Study Based on Structure Survey in Japan. Int J Radiat Oncol Biol Phys. Apr 4, 2011 [Epub ahead of print] [Pubmed]

Numasaki H, Shibuya H, Nishio M, Ikeda H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Ando Y, Tsukamoto N, Terahara A, Nakamura K, Mitsumori M, Nishimura T, Hareyama M, Teshima T, Japanese Society Therapeutic Radiology Oncology Database Committee. Japanese structure survey of radiation oncology in 2007 with special reference to designated cancer care hospitals. Strahlenther Onkol. 187(3):167-74, 2011. [Pubmed]

Ogata T, Koizumi M, Sumida I, Takahashi Y, Akino Y, Isohashi F, Konishi K, Yoshioka Y, Inoue T. Weekly verification of docimetric data for virtual wedge using a 2D diode detector array. Med.Dosim. 36(3):246-9, 2011. [Pubmed]

Ogata T, Teshima T, Inaoka M, Minami K, Tsuchiya T, Isono M, Furusawa Y, Matsuura N. Carbon ion irradiation suppresses metastatic potential of human non-small celllung cancer A549 cells through the phosphatidylinositol-3-kinase/Akt signaling pathway. J Radiat Res. 52(3): 374-9, 2011. [Pubmed]

Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Araya M, Mukumoto N, Teshima T, Mitsumori M. Japanese Patterns of Care Study Working Subgroup of Prostate Cancer. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: changing trends in the patterns of care process survey. Int J Radiat Oncol Biol Phys. 81(5):1310-8, 2011. [Pubmed]

Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H, Saito T, Onishi H, Karasawa K, Nemoto K, Nishimura Y. Concurrent Radiotherapy and Gemcitabine for Unresectable Pancreatic Adenocarcinoma: Impact of Adjuvant Chemotherapy on Survival. Int J Radiat Oncol Biol Phsy, Oct 20, 2011 [Epub ahead of print] [Pubmed]

Ogawa K, Ishiuchi S, Inoue O, Yoshii Y, Saito A, Watanabe T, Iraha S, Toita T, Kakinohana Y, Ariga T, Kasuya G, Murayama S. Phase II Trial of Radiotherapy after Hyperbaric Oxygenation with Multiagent Chemotherapy (Procarbazine, Nimustine, and Vincristine) for High-Grade Gliomas: Long-Term Results. Int J Radiat Oncol Biol Phys. Mar 17, 2011 [Epub ahead of print] [Pubmed]

Ogawa K, Chiba I, Morioka T, Shimoji H, Tamaki W, Takamatsu R, Nishimaki T, Yoshimi N, Murayama S. Clinical significance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy. Anticancer Res. 31(6):2351-9, 2011. [Pubmed]

Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y; JROSG Working Subgroup of Gastrointestinal Cancers. Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys. 80(1):111-8, 2011. [Pubmed]

Ono T., Takegawa H., Ageishi T., Takashina M., Numasaki H., Matsumoto M., Teshima T. Respiratory monitoring with an acceleration sensor. Phys. Med. Biol. 56(19): 6279-6289, 2011. [Pubmed]

Otani K, Y. Kawaguchi Y, Nishiyama K, Suzuki O, Nakamura S, Inaji H. Radiation-induced Organizing Pneumonia after Breast-conserving Therapy: Is Corticosteroid Necessary? Int J Radiat Oncol Biol Phys. 81(2): S232, 2011.

Ozawa S., Tachimori Y., Baba H., Matsubara H., Muro K., Numazaki H., Oyama T., Shinoda M., Takeuchi H., Tanaka O., Teshima T., Udagawa H., Uno T., Barron J.P. Comprehensive Registry of Esophageal Cancer in Japan, 2003. Esophagus 8: 9-29, 2011.

Ozawa S., Tachimori Y., Baba H., Matsubara H., Muro K., Numazaki H., Oyama T., Shinoda M., Takeuchi H., Tanaka O., Teshima T., Udagawa H., Uno T., Barron J.P. The Registration Committee for Esophageal Cancer.: Comprehensive Registry of Esophageal Cancer in Japan, 2003. The Japan Esophageal Society (Chiba), March 2011.

Satoh T, Yamanaka H, Yamashita T, Aoki M, Egawa S, Saito S, Sakata S, Shibuya H, Sugiura N, Takahashi Y, Nishimura T, Hamada T, Miki T, Yorozu A, Dokiya T. Deaths within 12 months after 125I implantation for brachytherapy of prostate cancer: An investigation of radiation safety issues in Japan (2003 - 2010). Brachytherapy 11(3): 192-6, 2012. [Pubmed]

Sumida I, Yamaguchi H, Kizaki H, Koizumi M, Ogata T, Takahashi Y, Yoshioka Y. Quality assurance of MLC leaf position accuracy and relative dose effect at the MLC abutment region using an electronic portal imaging device (In submission for J Radiat Res ) 2011. [Pubmed]

Takahashi Y, Koizumi M, Sumida I, Suga M, Konishi K, Yoshioka Y, Isohashi F, Ogata T, Akino Y, Yagi M, Ogawa K. Feasibility of a metal?oxide?semiconductor ?eld effect transistor detector linear array for in vivo dosimetry in high-dose-rate interstitial volume implant brachytherapy with an Ir-192 source (In submission for Med Phys) 2011.

Takahashi Y, Koizumi M, Sumida I, Isohashi F, Ogata T, Akino Y, Maruoka S, Inoue S, Konishi K, Yagi M, Wakai N, Yoshioka Y. Independent patient-specific treatment planning verification method using a benchmark plan identifies errors and gives an indicator for applicator insertion technique in high-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix (In submission for J. Rad. Res.) 2011.

Tanaka E, Yamazaki H, Yoshida K, Takenaka T, Masuda N, Kotsuma T, Yoshioka Y, Inoue T. Objective and longitudinal assessment of dermatitis following post-operative Accelerated Partial Breast Irradiation (APBI) using High Dose Rate Interstitial Brachytherapy (HDR-ISBT) in patients with breast cancer treated with Breast Conserving Therapy:Reduction of moisture deterioration by APBI. Int J Radiat Oncol Biol Phys. 81:1098-1104, 2011. [Pubmed]

Takaha N, Okihara K, Kamoi K, Kimura Y, Yamada T, Kawauchi A, Kobayashi K, Yamazaki H, Nishimura T, Miki T. Optimal duration of androgen deprivation in combination with radiation therapy for Japanese men with high-risk prostate cancer. Urol Int. 87: 28-34, 2011. [Pubmed]

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N. Prospective Multi-Institutional Study of Definitive Radiotherapy With High-Dose-Rate Intracavitary Brachytherapy in Patients With Nonbulky (<4-cm) Stage I and II Uterine Cervical Cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys. 82:e49-56, 2012(Epub Apr 4, 2011) [Pubmed]

Tomita N., Toita T., Kodaira T., Shinoda A., Uno T., Numasaki H., Teshima T., Mitsumori M. Changing trend in the patterns of pretreatment diagnostic assessment for patients with cervical cancer in Japan. Gynecol Oncol. 123(3): 577-80, 2011. [Pubmed]

Ueda Y, Miyazaki M, Nishiyama K, Suzuki O, Tsujii K, Miyagi K.Craniocaudal Safety Margin Calculation Based on Interfractional Changes in Tumor Motion in Lung SBRT Assessed with an EPID in Cine Mode. Int J Radiat Oncol Biol Phys. 83(3):1064-9, 2012. [Pubmed]

Yamazaki H, Shiomi H, Tsubokura T, Kodani N, Nishimura1 T, Aibe N, Udono H, Nishikata M, Baba Y, Ogita M, Yamashita K, Kotsuma T. Quantitative assessment of inter-observer variability in target volume delineation on stereotactic radiotherapy treatment for pituitary adenoma and meningioma near optic tract. Radiat Oncol.6: 10, 2011. [Pubmed]

Yamazaki H, Yoshida K, Nishimura T, Kobayashi K, Tsubokura T, Kodani N, Aibe N, Nhishimura T. Association between Skin Phototype and Radiation Dermatitis in Patients with Breast Cancer Treated with Breast-conserving Therapy: Suntan Reaction could be a Good Predictor for Radiation Pigmentation. J Radiat Res. 52: 496-501, 2011. [Pubmed]

Yamazaki H, Kodani N, Ogita M, Sato K, Himei K. Reirradiation of Head and Neck Cancer Focusing on Hypofractionated Stereotactic Body Radiation Therapy. Radiat Oncol 6: 98, 2011. [Pubmed]

Yoshida T, Nakayama M, Suzuki O, Matsuzaki K, Kobayashi Y, Takeda K, Arai Y, Kakimoto K, Nishiyama K, Nishimura K. Salvage radiotherapy for prostate-specific antigen relapse after radical prostatectomy for prostate cancer: a single-center experience. Jpn J Clin Oncol. 41:1031-1036, 2011. [Pubmed]

Yoshioka Y, Konishi K, Sumida I, Takahashi Y, Isohashi F, Ogata T, Koizumi M, Yamazaki H, Nonomura N, Okuyama A, Inoue T. Monotherapeutic high-dose-rate brachytherapy for prostate cancer: Five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions. Int J Radiat Oncol Biol Phys. 80:469-475, 2011. [Pubmed]

2010

Ba K, Li X, Wong H, Liu Y, Zheng G, Yang Z, Li M, Shimizutani K, Koseki T: Correlation between imaging features and epithelial cell proliferation in keratocystic odontogenic tumours. Dentomaxillofacial Radiology 39: 368-374, 2010. [Pubmed]

Hamada N, Imaoka T, Masunaga S, Ogata T, Okayasu R, Takahashi A, Kato TA., Kobayashi Y, Ohnishi T, Ono K, Shimada Y, Teshima T: Recent advances in the biology of heavy-ion cancer therapy. J Radiat Res 51(4): 365-83, 2010. [Pubmed]

Harada H, Katagiri H, Kamata M, Yoshioka Y, Asakura H, Hashimoto T, Furutani K, Takahashi M, Sakahara H, Nishimura T: Radiological response and clinical outcome in patients with femoral bone metastases after radiotherapy. J Radiat Res 51: 131-136, 2010. [Pubmed]

Hashimoto N, Iwazawa J, Abe H, Mitani T, Kagawa K: Radiation therapy for gastric wall metastasis from esophageal carcinoma. Jpn J Radiol 28: 227-230, 2010. [Pubmed]

Ishihara R, Yamamoto S, Iishi H, Takeuchi Y, Sugimoto N, Higashino K, Uedo N, Tatsuta M, Yano M, Imai A, Nishiyama K: Factors Predictive of Tumor Recurrence and Survival After Initial Complete Response of Esophageal Squamous Cell Carcinoma to Definitive Chemoradiotherapy. Int J Radiat Oncol Biol Phys 76(1): 123-9, 2010. [Pubmed]

Isohashi F, Yoshioka Y, Koizumi M, Suzuki O, Konishi K, Sumida I, Takahashi Y, Ogata T, Kotsuma T, Inoue T: Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 77: 758-764, 2010. [Pubmed]

Japanese PCS Working Group: Radiation Oncology in Multidisciplinary Cancer in Multidisciplinary Cancer Therapy-Basic requirements for quality assurance of radiotherapy based on Patterns of Care Study. 2010. 10. Conclusions 分担執筆Ministry of Health, Labour and Welfare Cancer Research Grant, Planned Research Study 18-4, 78-79, 2010.

Liu Y, You M, Wong H, Yang Z, Miao J, Shimizutani K, Koseki T: Ossifying fibromas of the jaw bone: 20 cases. Dentomaxillofacial Radiology 39: 57-63, 2010. [Pubmed]

Mabuchi S, Isohashi F, Yoshioka Y, Temma K, Takeda T, Yamamoto T, Enomoto T, Morishige K, Inoue T, Kimura T: Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapy. Int J Gynecol Cancer 20: 834-840, 2010. [Pubmed]

Mabuchi S, Ugaki H, Isohashi F, Yoshioka Y, Temma K, Yada-Hashimoto N, Takeda T, Yamamoto T, Yoshino K, Nakajima R, Kuragaki C, Morishige K, Enomoto T, Inoue T, Kimura T: Concurrent weekly nedaplatin, external beam radiotherapy, and high-dose rate brachytherapy in patients with FIGO stage IIIB cervical cancer: a comparison with a cohort treated by radiotherapy alone. Gynecol Obstet Invest 69: 224-232, 2010. [Pubmed]

Mochimaru Y, Ohno Y, Numasaki H, Teshima T, Shibuya H: JASTRO Committee. Relations between Radiotherapy Resources and Breast Cancer Patient Survival Rates. Asian Pac J Cancer Prev 11(2): 513-517, 2010. [Pubmed]

Morimoto M, Nishiyama K, Nakamura S, Suzuki O, Kawaguchi Y, Nakajima A, Imai A, Ishihara R, Uemura H, Fujii T, Yoshino K, Tomita Y. Significance of endoscopic screening and endoscopic resection for esophageal cancer in patients with hypopharyngeal cancer. Jpn J Clin Oncol, 40(10): 938-943, 2010. [Pubmed]

Nishida T, Tsutsui S, Yamamoto K, Konishi K, Hayashi Y, Iijima H, Tsujii M, Takeda Y, Kitagawa T, Yoshioka Y, Inoue T, Hayashi N: Phase I trial of gemcitabine dose escalation with concurrent radiotherapy for patients with locally advanced pancreatic cancer. Pancreatology 10: 60-65, 2010. [Pubmed]

Nishikino M, Sato K, Hasegawa N, Ishino M, Ohshima S, Okano Y, Kawachi T, Numasaki H, Teshima T, Nishimura H: Application of Laser Produced Plasma Kα X-ray Probe in Radiation Biology. Rev Sci Instrum, 81(4): 026107, 2010. [Pubmed]

Ogata T, Yamazaki H, Teshima T, Kihara A, Suzumoto Y, Inoue T, Nishimoto N, Matsuura N. Early administration of IL-6RA does not prevent radiation-induced lung injury in mice. Radiat Oncol 5: 26, 2010. [Pubmed]

Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Araya M, Mukumoto N, Teshima T, Mitsumori M: Radical external beam radiotherapy for clinically localized prostate cancer in Japan: Changing trends in the Patterns of Care process survey. Int J Radiat Oncol Biol Phys Oct 13(Epub ahead of print), 2010. [Pubmed]

Otani Y, Fukuda I, Tsukamoto N, Kumazaki Y, Sekine H, Imabashi E, Kawaguchi O, Nose T, Teshima T, Dokiya T: A comparsion of the respiratory signals acquired by different respiratory monitoring systems used in respiratory gated radiotherapy. Med Phys 37(12): 6178-6186, 2010. [Pubmed]

Ozawa S, Tachimori Y, Baba H, Matsubara H, Muro K, Numazaki H, Oyama T, Shinoda M, Takeuchi H, Tanaka O, Teshima T, Udagawa H, Uno T, Barron J.P,: Comprehensive Registry of Esophageal Cancer in Japan, 2002. Esophagus 7: 7-22, 2010.

Ozawa S, Tachimori Y, Baba H, Matsubara H, Muro K, Numazaki H, Oyama T, Shinoda M, Takeuchi H, Tanaka O, Teshima T, Udagawa H, Uno T, Barron J.P: The Registration Committee for Esophageal Cancer.: Comprehensive Registry of Esophageal Cancer in Japan, 2002. The Japan Esophageal Society (Chiba), March 2010.

Sakabe T, Murata H, Konishi E, Koto K, Horie N, Matsui T, Sawai Y, Yamazaki H, Kagiya T, Kubo T. High Efficacy of Preoperative Low-Dose Radiotherapy with Sanazole (AK-2123) for Extraskeletal Ewing's Sarcoma: A Case Report. Sarcoma 6: 2011, 2010. [Pubmed]

Sato K., Nishikino M., Okano Y., Ohshima S., Hasegawa N., Ishino M., Kawachi T., Numasaki H., Teshima T., Nishimura H.:γ-H2AX and phoshorylated ATM focus formation on cancer cell line by laser plasma x-ray irradiation. Radiat Research 174(4): 436-45, 2010. [Pubmed]

Takahashi Y, Koizumi M, Sumida I, Ogata T, Akino Y, Yoshioka Y, Konishi K, Isohashi F, Ota S, Inoue T: What is the optimum minimum segment size used in step and shoot IMRT for prostate cancer? J Radiat Res 51: 543-552, 2010. [Pubmed]

Teshima, T, Numasaki, H, Shibuya, H, Nishio, M, Ikeda, H, Sekiguchi, K, Kamikonya, N, Koizumi, M, Tago, M, Ando, Y, Tsukamoto, N, terahara, A, Nakamura, K, Mitsumori, M, Nishimura, T, Hareya,am M and JASTRO Database Committee: Japanese structure survey of radiation oncology in 2007 based on institutional stratification of Patterns of Care Study. Int J Radit Oncolo Biol Phys 78(5): 1483-93, 2010. [Pubmed]

Yamazaki H, Yoshida K, Kotsuma T, Yoshioka Y, Koizumi M, Furukawa S, Kakimoto N, Shimizutani K, Nishimura T: Age is not a limiting factor for brachytherapy for carcinoma of the node negative oral tongue in patients aged eighty or older. Radiat Oncol 5:116, 2010. [Pubmed]

Yamazaki H. Response to "Helical Tomotherapy for Simultaneous Multitarget Radiotherapy for Pulmonary Metastasis." Int J Radiat Oncol Biol Phys 76: 1276, 2010. [Pubmed]

Yoshida K, Yamazaki H, Takenaka T, Kotsuma T, Yoshida M, Furuya S, Tanaka E, Uegaki T, Kuriyama K, Matsumoto H, Yamada S, Ban C: A dose–volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial Brachytherapy for uterine cervical cancer. Int J Radiat Oncol Biol Phys 77: 765–772, 2010. [Pubmed]

Yoshida K, Yamazaki H, Nose T, Shiomi H, Yoshida M, Mikami M, Takenaka T, Kotsuma T, Tanaka E, Kuriyama K, Harada Y, Tohda A, Yasunaga Y, Oka T: Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy 9: 36-41, 2010. [Pubmed]

Yoshida K, Yamazaki H, Takenaka T, Tanaka E, Kotsuma T, Fujita Y, Masuda N, Kuriyama K, Yoshida M, Nishimura T: Objective assessment of dermatitis following post-operative radiotherapy in patients with breast cancer treated with breast-conserving treatment. Strahlenther Onkol 186: 621-9, 2010. [Pubmed]

2009

Akino Y, Teshima T, Kihara A, Kodera-Suzumoto Y, Inaoka M, Furusawa Y, Higashiyama S, Matsuura N. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small cell lung cancer cells. Int J Radiat Oncol Biol Phys 75: 475-481, 2009. [Pubmed]

Isohashi F, Yoshioka Y, Koizumi M, Konishi K, Sumida I, Takahashi Y, Ogata T, Morishige K, Enomoto T, Kawaguchi Y, Kotsuma T, Adachi K, Fukuda S, Akino Y, Inoue T. High-dose-rate interstitial brachytherapy for previously untreated cervical carcinoma. Brachytherapy 8: 234-239, 2009. [Pubmed]

Uchiyama Y, Murakami S, Kakimoto N, Nakatani A, Kishino M, Hamab Y, Furukawa S. Diagnostic imaging findings for mandibular metastasis from gastric adenocarcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont. 107(6): e49-e53, 2009. [Pubmed]

Uchiyama Y, Murakami S, Kishino M, Furukawa S. Ameloblastic fibro-odontoma arising in the mandible: Three case reports. Oral Radiol. 25(1): 71-76, 2009.

Utsumi T, Shiono H, Kadota Y, Matsumura A, Maeda H, Ohta M, Yoshioka Y, Koizumi M, Inoue T, Okumura M. Postoperative radiation therapy after complete resection of thymoma has little impact on survival. Cancer 115: 5413-5420, 2009. [Pubmed]

Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Shioyama Y, Araya M, Mukumoto N, Mitsumori M, Teshima T. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months. Int J Radiat Oncol Biol Phys 74(3):759-65, 2009. [Pubmed]

Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Araya M, Mukumoto N, Mitsumori M, Teshima T. Postoperative radiotherapy for localized prostate cancer: clinical significance of nadir prostate-specific antigen value within 12 months. Anticancer Res 29(11):4605-13, 2009. [Pubmed]

Ozawa S, Tachimori Y, Baba H, Matsubara H, Muro K, Numasaki H, Oyama T, Shinoda M, Takeuchi H, Tanaka O, Teshima T, Udagawa H, Uno T, Yamana H, Konishi T, and J. P. Barron. Comprehensive Registry of Esophageal Cancer in Japan, 2001, Esophagus 6, 95-110, 2009.

Kakimoto N, Gamoh S, Tamaki J, Kishino M, Murakami S, Furukawa S. CT and MR images of pleomorphic adenoma in major and minor salivary glands. Eur J Radiol.69(3): 464-472, 2009. [Pubmed]

Kenjo M, Uno T, Murakami Y, Nagata Y, Oguchi M, Saito S, Numasaki H, Teshima T, and Mitsumori M. Radiation therapy for esophageal cancer in Japan: Results of the Patterns of Care Study 1999-2001, Int J Radiat Oncol Biol Phys 75, 357-363, 2009. [Pubmed]

Kobayashi S, Nagano H, Marubashi S, Takeda Y, Tanemura M, Konishi K, Yoshioka Y, Inoue T, Doki Y, Mori M. Impact of postoperative irradiation after non-curative resection of hilar biliary cancer. J Surg Oncol 100: 657-662, 2009. [Pubmed]

Konishi K, Yoshioka Y, Isohashi F, Sumida I, Kawaguchi Y, Kotsuma T, Adachi K, Morimoto M, Fukuda S, Inoue T. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 75: 1003-1007, 2009. [Pubmed]

Sasaki T, Nakamura K, Ogawa K, Onishi H, Okamoto A, Koizumi M, Shioyama Y, Mitsumori M, Teshima T. Radiotherapy for patients with localized hormone-refractory prostate cancer: results of the Patterns of Care Study in Japan. BJU Int 104(10):1462-6, 2009. [Pubmed]

Sanuki-Fujimoto N, Sumi M, Ito Y, Imai A, Kagami Y, Sekine I, Kunitoh H, Ohe Y, Tamura T, Ikeda H. Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses. Radiotherapy and oncology 91(3): 433-7, 2009. [Pubmed]

Shimamoto, H, Kakimoto, N, Fujino, K, Hamada, S, Shimosegawa, E, Murakami, S, Furukawa, S, Hatazawa, J. Metallic artifacts caused by dental metal prostheses on PET images: A PET/CT phantom study using different PET/CT scanners. Annals of Nuclear Medicine. 23(5): 443-449, 2009. [Pubmed]

Sumida I, Koizumi M, Takahashi Y, Ogata T, Akino Y, Isohashi F, Konishi K, Yoshioka Y, Inoue T. Verification of air-kerma strength of 125I seed for permanent prostate implants in Japan. Int J Clin Oncol 14: 525-528, 2009. [Pubmed]

Chindasombatjaroen J, Uchiyama Y, Kakimoto N, Murakami S, Furukawa S, Kishino, M. Postoperative maxillary cysts: Magnetic resonance imaging compared with computerized tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont.107 (5): e38-e44, 2009. [Pubmed]

Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kodaira T, Kazumoto T, Kataoka M, Shikama N, Kenjo M, Teshima T, Kagami Y. Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: The individual case review in Japan. Jpn.J.Clin. Oncol.39(12): 813-819, 2009. [Pubmed]

Nakamura K, Ogawa K, Sasaki T, Onishi H, Koizumi M, Araya M, Mukumoto N, Mitsumori M, Teshima T. Patterns of radiation treatment planning for localized prostate cancer in Japan: 2003-05 patterns of care study report. Jpn J Clin Oncol 39(12):820-4, 2009. [Pubmed]

Numasaki H, Teshima T, Shibuya H, Nishio M, Ikeda H, Ito H, Sekiguchi K, Kamikonya N, Koizumi M, Tago M, Nagata Y, Masaki H, Nishimura T, Yamada S. National structure of radiation oncology in Japan with special reference to designated cancer care hospitals. Int J Clin Oncol 14(3):237-44, 2009. [Pubmed]

Fuji H, Asada Y, Numano M, Yamashita H, Nishimura T, Hashimoto T, Harada H, Asakura H, Murayama S. Residual motion and duty time in respiratory gating radiotherapy using individualized or population-based windows. Int J Radiat Oncol Biol Phys, 75: 564-570, 2009. [Pubmed]

Fujitani K, Tsujinaka T, Yamasaki H, Hirao M, Yoshida K, Kurokawa Y. Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy. Anticancer Res. 29: 3385-91, 2009. [Pubmed]

Mabuchi S, Morishige KI, Isohashi F, Yoshioka Y, Takeda T, Yamamoto T, Yoshino K, Enomoto T, Inoue T, Kimura T. Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. Gynecol Oncol 115: 482-487, 2009. [Pubmed]

Miyakoshi M, Tomiyasu M, Bagarinao E, Murakami S, Nakai T. A Phantom Study On Component Segregation for MR Images Using ICA. Academic Radiol. 16(8): 1025-1028, 2009. [Pubmed]

Mukumoto N, Tsujii K, Saito S, Yasunaga M, Takegawa H, Yamamoto T, Numasaki H, and Teshima, T. A preliminary study for in-house Monte Carlo simulations: An integrated Monte Calro verification system. Int J Radiat Oncol Biol Phys 75: 571-579, 2009. [Pubmed]

Yamazaki H, Inoue T, Yoshida K, Kotsuma T, Yoshioka Y, Koizumi M, Furukawa S, Kakimoto N, Shimizutani K, Nishimura T. Assessment of influence of smoking, drinking, leukoplakia and dental irritation on local control of early oral tongue carcinoma treated with brachytherapy: age and dental factors are potential prognostic factors. Tumori 95: 461-466, 2009. [Pubmed]

Yamazaki H, Yoshida K, Kotsuma T, Kuriyama K, Masuda N, Nishimura T, Kobayashi K, Tsubokura T, Nishimura T. Longitudinal practical measurement of skin color and moisture during and after breast-conserving therapy: influence of neoadjuvant systemic therapy. Jpn J Radiol 27(8): 309-15, 2009. [Pubmed]

Yogo A, Sato K, Nishikino M, Mori M, Teshima T, Numasaki H, Murakami M, Demizu Y, Akagi S, Nagayama S, Ogura K, Sagisaka A, Orimo S, Nishiuchi M, A. S. Pirozhkov, Ikegami M, Tampo M, Sakaki H, Suzuki M, Daito I, Oishi Y, Sugiyama H, Kiriyama H, Okada H, Kanazawa S, Kondo S, Shimomura T, Nakai Y, Tanoue M, Sasao H, Wakai D, P. R. Bolton, and Daido H. Application of laser-accelerated protons to the demonstration of DNA double-strand breaks in human cancer cells, Appl. Phys. Lett, 94: 181502-1-181502-3, 2009.

Yoshioka Y. Current status and perspectives of brachytherapy for prostate cancer. Int J Clin Oncol 14: 31-36, 2009. [Pubmed]

Yoshioka Y, Suzuki O, Kobayashi K, Teshima T, Yamada Y, Kotsuma T, Koizumi M, Kagawa K, Chatani M, Shimamoto S, Tanaka E, Yamazaki H, Inoue T. External-beam radiotherapy for clinically localized prostate cancer in Osaka, Japan, 1995-2006: Time trends, outcome, and risk stratification. Strahlenther Onkol 185: 446-452, 2009. [Pubmed]

Yoshida K, Nose T, Masuda N, Yamazaki H, Kotsuma T, Yoshida M, Yamamura J, Masuda H, Shin E, Nakaba H, Komoike Y, Tokuda Y, Takeda M, Kuriyama K. Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer. 16:105-12, 2009. [Pubmed]

2008

Adachi S, Yashiro K, Montero E. C, Abe N, Shigenaga N, Uchiyama Y, Murakami S, Takada K. Dynamic stereometry of the human temporomandibular joint by means of CT/MRI. In Silico Dentistry -the evolution of computational oral health science- 91-94, 2008.

Isohashi F, Endo H, Mukai M, Inoue T, Inoue M. Insulin-like growth factor stimulation increases radiosensitivity of a pancreatic cancer cell line through endoplasmic reticulum stress under hypoxic conditions. Cancer Sci. 99(12): 2395-2401, 2008. [Pubmed]

Kakimoto N, Gamoh S, Tamaki J, Murakami S, Furukawa S. Three-dimensional analysis of facial morphology of Japanese young women with normal occlusion using multidetector CT. In Silico Dentistry -the evolution of computational oral health science- 49-53, 2008.

Kataoka M, Uchiyama Y, Kakimoto N, Sasai T, Murakami S, Furukawa S, Kishino M. Oral administration of Bisphosphonate associated osteomyelitis of jaw: A case report. In Silico Dentistry -the evolution of computational oral health science- 114-117, 2008.

Mizuno, H, Kanai, T, Kusano, Y, Ko, S, Ono, M, Fukumura, A, Abe, K, Nishizawa K, Shimbo, M, Sakata, S, Ishikura, S, Ikeda, H: Feasibility study of glass dosimeter postal dosimetry audit of high-energy radiotherapy photon beams. Radiother Oncol 86: 258-63, 2008. [Pubmed]

Murakami S, Maeda Y, Ghanem A, Uchiyama Y, Kreiborg S. Influence of mouthguard on temporomandibular joint. Scand J Med Sci Sports 2008 Jan 14. [Epub ahead of print], 2008. [Pubmed]

Murakami S, Nakai T, Matsuo N. Kakimoto N and Yamamoto T. Brain activation on salty stimulus using functional MR imaging. In Silico Dentistry -the evolution of computational oral health science- 138-141, 2008.

Nose T, Koizumi M, Yoshida K, Nishiyama K, Sasaki J, Ohnishi T, Kozuka T, Gomi K, Oguchi M, Sumida I, Takahashi Y, Ito A, Yamashita T. In vivo dosimetry of high-dose-rate interstitial brachytherapy in the pelvic region: use of a radiophotoluminescence glass dosimeter for measurement of 1004 points in 66 patients with pelvic malignancy. Int J Radiat Oncol Biol Phys 70:626-33, 2008. [Pubmed]

Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Araya M, Shioyama Y, Okamoto A, Mitsumori M, Teshima T, Japanese PCS Working Subgroup of Prostate Cancer. Radical external beam radiotherapy for prostate cancer in Japan: differences in the patterns of care among Japan, Germany, and the United States. Radiation Medicine 26: 57-62, 2008. [Pubmed]

Shimamoto H, Tatsumi M, Kakimoto N, Hamada S, Shimosegawa E, Murakami S, Furukawa S, Hatazawa J. (18)F-FDG accumulation in the oral cavity is associated with periodontal disease and apical periodontitis: an initial demonstration on PET/CT. Ann Nucl Med 2008 Aug;22(7):587-93, 2008. [Pubmed]

Suzuki O, Yoshioka Y, Isohashi F, Morimoto M, Kotsuma T, Kawaguchi Y, Konishi K, Nakamura S, Shiomi H, Inoue T. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer. Int J Radiat Oncol Biol Phys 71: 1329-1334, 2008. [Pubmed]

Tanaka S, Iida S, Murakami S, Kishino M, Yamada C, Okura M. Extensive nasopalatine duct cyst causing nasolabial protrusion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jul 23. [Epub ahead of print], 2008. [Pubmed]

Teshima, T, Numasaki, H, Shibuya, H, Nishio, M, Ikeda, H, Ito, H, Sekiguchi, K, Kamikonya, N, Koizumi, M, Tago, M, Nagata, Y, Masaki H, Nishimura, T, Yamada, S and Japanese Society of therapeutic Radiology and Oncology Database Committee: Japanese structure survey of radiation oncology in2005 based on institutional stratification of Patterns of Care Study. Int J Radit Oncolo Biol Phys 72:144-52, 2008. [Pubmed]

Toita T, Kodaira T, Shinoda A,Uno T, Akino Y, Misumori M, Teshima T. Patterns of radiotherapy practice for patients with cervical cancer (1999-2001): Patterns of Care Study in Japan. Int. J. Radiat. Oncol. Biol. Phys 70(3): 788-794, 2008. [Pubmed]

Toita T, Kodaira T, Uno T, Shinoda A, Akino Y, Misumori M, Teshima T. Patterns of pretreatment diagnostic assessment and staging for patients with cervical cancer (1999-2001): Patterns of Care Study in Japan. Jpn.J.Clin. Oncol.38(1): 26-30, 2008. [Pubmed]

Tomita S, Kakimoto N, Kataoka M, Chindasombatjaroen J, Nakatani A, Uchiyama Y, Murakami S, Furukawa S. Volume measurement of tongue cancers by CT and MRI. In Silico Dentistry -the evolution of computational oral health science- 110-113, 2008.

Uno T, Sumi M, Ishihara Y, Numasaki H, Mitsumori M, Teshima T, for the Japanese PCS Working Subgroup of Lung Cancer. Changes in patterns of care for limited –stage small cell lung cancer: Results of the 99-01 Patterns of Care Study-A nationwide survey in Japan. Int. J. Radiat. Oncol. Biol. Phys. 71(2): 414-419, 2008. [Pubmed]

Yamazaki H, Yoshida K, Yoshioka Y, Isohashi F, Ozeki S, Koizumi M, Yoneda M, Inoue T. Impact of mitochondrial DNA on hypoxic radiation sensitivity in human fibroblast cells and osteosarcoma cell lines. Oncol Rep 19: 1545-1549, 2008. [Pubmed]

Yashiro K, Kageyama A, Yamamoto K, Uchiyama Y, Murakami S, Takada K. Optimality of horizontal movement direction of the working-side condyle for non-symptomatic temporomandibular joint. In Silico Dentistry -the evolution of computational oral health science- 84-86, 2008.

Yoshida K, Yamazaki H, Nose T, Shiomi H, Kotsuma T, Yoshida M, Kuriyama K, Oka T. Ambulatory high dose rate interstitial implant brachytherapy system for prostate cancer. Nowotwory Journal of Oncology 58:144–146, 2008.

2007

Hosoi H, Iehara T, Tsuchiya K, Misawa A, Miyaji M, Yagyu S, Koizumi M, Nishimura T, Tokiwa K, Iwai N, Yanagisawa A, Sugimoto T. Continuous remission in an infant with chest wall malignant rhabdoid tumor after relapse. J Pediatr Surg. 42:E9-12, 2007. [Pubmed]

Ikeda K, Koseki T, Maehara M, Ohmura N, Kurokawa H, Shimizutani K, Sawada S. Hourglass-shaped sublingual dermoid cyst: MRI features. Radiat Med 25: 306-308, 2007. [Pubmed]

Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Oguchi M. Initial experience with the quality assurance program of radiation therapy on behalf of Japan Radiation Oncology Group (JAROG). Jpn J Clin Oncol 37(2): 135-139, 2007. [Pubmed]

Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Oguchi M. A multicenter phase II study of local radiotherapy for stage IEA mucosa associated lymphoid tissue lymphomas: A preliminary report from Japan Radiation Oncology Group (JAROG). Int J Radiat Oncol Biol Phys 69(4): 1181-1186, 2007. [Pubmed]

Kakimoto N, Murakami S, Shimizutani K, Furukawa S. High-dose-rate interstitial brachytherapy for T3 tongue cancer. Dentistry in Japan 43: 104-108, 2007.

Kumazaki Y, Akagi T, Suga D, Hishikawa Y, Teshima T. Determination of the mean excitation energy of water from proton beam ranges.  Radiation Measurements  42: 1683-1691, 2007.

Mayahara H., Murakami M., Kagawa, K., Kawaguchi A., Oda Y., Miyawaki D., Sasaki R., Sugimura K., Hishikawa Y. Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center Experience. Int J Radiat Oncol Biol Phys 69(2): 434-443, 2007. [Pubmed]

Murakami Y, Kenjo M, Uno T, Oguchi M, Shimada M, Teshima T, Results of the 1999-2000 Japanese patterns of care study for patients receiving definitive radiation therapy without surgery for esophageal cancer. Jpn J Clinical Oncol 37(7): 493-500, 2007. [Pubmed]

Nose T, Koizumi M, Yoshida K, Nishiyama K, Sasaki J, Ohnishi T, Kozuka T, Gomi K, Oguchi M, Sumida I, Takahashi Y, Ito A, Yamashita T. In Vivo Dosimetry of High-Dose-Rate Interstitial Brachytherapy in the Pelvic Region: Use of a Radiophotoluminescence Glass Dosimeter for Measurement of 1004 Points in 66 Patients with Pelvic Malignancy. Int J Radiat Oncol Biol Phys. 70:626-633, 2007. [Pubmed]

Suzuki O, Shiomi H, Nakamura S, Nakayama F, Yoshioka Y, Inoue T. Novel correction methods as alternatives for the six-dimensional correction in CyberKnife treatment. Radiat Med 25: 31-37, 2007. [Pubmed]

Uno T , Sumi M, Kihara A, Numasaki H, Kawakami H, Ikeda H, Mitsumori M, Teshima T. Postoperative radiotherapy for non-small-cell lung cancer: results of the 1999-2001 patterns of care study nationwide process survey in Japan . Lung Cancer 56: 357-362, 2007. [Pubmed]

Yamamoto T, Mizowaki T, Miyabe Y, Takegawa H, Narita Y, Yano S, Nagata Y, Teshima T, Hiraoka M.  An integrated Monte Carlo dosimetric verification system for radiotherapy treatment planning. Physics in Medicine and Biology 52: 1991-2008, 2007. [Pubmed]

Yamauchi C, Mitsumori M, Sai H, Imagunbai T, Negoro Y, Sasaki Y, Hiraoka M, Shikama N, Sasaki S, Takegawa H, Inoue T, Teshima T. Patterns of Care Study of breast-conserving therapy in Japan : Comparison of the treatment process between 1995-1997 and 1999-2001 surveys.  Jpn J Clin Oncol 37(10): 737-743, 2007. [Pubmed]

Yamazaki H, Nishiyama K, Koizumi M, Tanaka E, Ioka T, Uehara H, Iishi H, Nakaizumi A, Ohigashi H, Ishikawa O. Concurrent chemoradiotherapy for advanced pancreatic cancer: 1,000 mg/m2 gemcitabine can be administered using limited-field radiotherapy. Strahlenther Onkol 183(6): 301-306, 2007. [Pubmed]

Yamazaki H, Inoue T, Yoshida K, Yoshioka Y, Furukawa S, Kakimoto N, Shimizutani K. Comparison of three major radioactive sources for brachytherapy used in the treatment of node negative T1-T3 oral tongue cancer: influence of age on outcome. Anticancer Res 27(1B): 491-497, 2007. [Pubmed]

Yamazaki H, Nishiyama K, Tanaka E, Koiwai K, Shikama N, Ito Y, Arahira S, Tamamoto T, Shibata T, Tamaki Y, Kodaira T, Oguchi M. Dummy run for a phase II multi-institute trial of chemoradiotherapy for unresectable pancreatic cancer: inter-observer variance in contour delineation. Anticancer Res 27(4C): 2965-2971, 2007. [Pubmed]

Yoshida K, Kuroda S, Yoshida M, Fujita Y, Sakai M, Nohara T, Kawashima A, Takahashi T, Tohda A, Oka T, Yamazaki H, Kuriyama K. New implant technique for separation of the seminal vesicle and rectal mucosa for high-dose-rate prostate brachytherapy. Brachytherapy. 6:180-186, 2007. [Pubmed]

Yoshioka Y, Inoue T. Prostate Risk Index (PRIX) as a new method of risk classification for clinically localized prostate cancer. Strahlenther Onkol 183: 490-496, 2007.

Takahashi Y, Tachibana H, Ito A, Kozuka T, Otani Y, Yamashita T. Feasibility study of real time in vivo dosimetry with MOSFET linear array in I-125 prostate permanent implant brachytherapy. Jpn J Med Phys 27 (suppl.4): 119-120, 2007.

[Pubmed]

2006

Akiyama H, Tamaki J, Shimamoto H, Ozono K, Tamaki J, Nakatani A, Uchiyama U, Murakami S, Furukawa S. First Branchial cleft cyst in the parotid area. Oral Radiology 22: 89-92, 2006.

Isohashi F, Inoue T, Xing S, Eren CB, Ozeki S, Inoue T. Postoperative Irradiation for Pterygium: Retrospective Analysis of 1,253 Patients from the Osaka University Hospital. Strahlenther Onkol 182: 437-442, 2006. [Pubmed]

Iwakawa M, Noda S, Yamada S, Yamamoto N, Miyazawa Y, Yamazaki H, Kawakami Y, Matsui Y, Tsujii H, Mizoe J, Oda E, Fukunaga Y, Imai T. Analysis of Non-Genetic Risk Factors for Adverse Skin Reactions to Radiotherapy among 284 Breast Cancer Patients. Breast Cancer 13: 300-307, 2006. [Pubmed]

Kakimoto N, Inoue T, Inoue T, Murakami S, Furukawa S, Yoshida K, Yoshioka Y, Yamazaki H, Tanaka E, Shimizutani K. High-dose-rate interstitial brachytherapy for mobile tongue cancer: influence of the non-irradiated period. Anticancer Res 26: 3933-3937, 2006. [Pubmed]

Kawashima M, Kagami Y, Toita T, Uno T, Sugiyama M, Tamura Y, Hirota S, Fuwa N, Hashimoto M, Yoshida H, Shikama N, Kataoka M, Akuta K, Sasaki K, Tamamoto T, Nemoto K, Ito H, Kato H, Yamada S, Ikeda H. Prospective trial of radiotherapy for patients 80 years of age or older with squamous cell carcinoma of the thoracic esophagus. Int J Radiat Oncol Biol Phys 64: 1112-1121, 2006. [Pubmed]

Murakami S, White SC, Uchiyama Y, Kakimoto N. Change of temporomandibular joint disk configuration and clinical findings following conservative treatment. Supplement of Conference on TMJ replacement and tissue engineering 17-20, 2006.

Nakamura T, Gamoh S, Akiyama H, Shimamoto H, Ozono K, Tamaki J, Nakatani A, Uchiyama U, Murakami S, Furukawa S. A primordial cyst without keratinization in the maxillary region. Oral Radiology 22: 86-88, 2006.

Niibe Y, Kazumoto T, Toita T, Yamazaki H, Higuchi K, Ii N, Suzuki K, Uno T, Tokumaru S, Takayama M, Sekiguchi K, Matsumoto Y, Michimoto K, Oguchi M, Hayakawa K. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. Gynecol Oncol 103: 435-438, 2006. [Pubmed]

Nose T, Komoike Y, Yoshida K, Koizumi M, Motomura K., Kasugai T, Inaji H, Nishiyama K, Koyama H, Kozuka T, Gomi K, Oguchi M, Takahashi Y, Sumida I, Yamashita T. A pilot study of wider indication for accelerated partial breast irradiation: Intraop re-excision combined with high-dose-rate interstitial brachytherapy. Breast Cancer 13: 289-299, 2006.

Ogawa K, Nakamura K, Ohnishi H, Koizumi M, Sasaki T, Araya M, Miyabe Y, Otani Y, Teshima T. Influence of Age on the Pattern and Outcome of External Beam Radiotherapy for Clinically Localized Prostate Cancer. Anticancer Res 26: 1319-1325, 2006. [Pubmed]

Ogawa K, Nakamura K, Onishi H, Sasaki T, Koizumi M, Shioyama ., Komiyama T, Miyabe T, Teshima T. Radical external beam radiotherapy for clinically localized prostate cancer in Japan: Differences in the Patterns of Care between Japan and the United States. Anticancer Res 26: 575-580, 2006. [Pubmed]

Oh RJ, Yoshioka Y, Tanaka E, Shiomi H, Sumida I, Isohashi F, Suzuki O, Konishi K, Kawaguchi Y, Nakamura S, Kato M, Inoue T. High-dose-rate brachytherapy combined with long-term hormonal therapy for high-risk prostate cancer: results of a retrospective analysis. Radiat Med 24: 58-64, 2006. [Pubmed]

Orhan K, Nishiyama H, Tadashi S, Murakami S, Furukawa S. Comparison of altered signal intensity, position, and morphology of the TMJ disc in MR images corrected for variations in surface coil sensitivity. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101: 515-522, 2006.

Sasaki T, Nakamura K, Ogawa K, Onishi H, Otani Y, Koizumi M, Shioyama Y, Teshima T. Postoperative Radiotherapy for Patients with Prostate Cancer in Japan; Changing Trends in National Practice between 1996-98 and 1999-2001: Patterns of Care Study for Prostate Cancer. Jpn J Clin Oncol 36: 649-654, 2006. [Pubmed]

Schweikard A, Shiomi H, Adler J. Respiration tracking in radiosurgery without fiducials. The International Journal of Medical Robotics and Computer Assisted Surgery 1(2): 19-27, 2006.

Shimamoto H, Ozono K, Nakamura T, Akiyama H, Gamoh S, Tamaki J, Kishino M, Uchiyama Y, Kato K, Murakami S, Furukawa S. Osteosarcoma in the maxilla: a case report. Oral Radiology 22: 37-40, 2006.

Sumida I, Shiomi H, Yoshioka Y, Inoue T, Lessard E, Hsu ICJ, Pouliot J. Optimization of dose distribution for HDR brachytherapy of the prostate using Attraction-Repulsion Model. Int J Radiat Oncol Biol Phys 64: 643-649, 2006. [Pubmed]

Takahashi Y, Ito A, Sumida I, Kozuka T, Gomi K, Nose T, Yamashita T. Dosimetric consideration of individual I-125 source strength measurement and the large-scale comparison of measured with nominal value in permanent prostate implant brachytherapy. Radiat Med. 24(2): 675-679, 2006. [Pubmed]

Takahashi Y, Mori S, Kozuka T, Gomi K, Nose T, Tahara T, Oguchi M, Yamashita T. Preliminary study of correction of original metal artifacts due to I-125 seeds in postimplant dosimetry for prostate permanent implant brachytherapy. Radiat Med. 24(2): 133-138, 2006. [Pubmed]

Takashima M, Kitai N, Murakami S, Takagi S, Hosokawa K, Kreiborg S, Takada K. Dual segmental distraction osteogenesis of the mid-face in a patient with Apert syndrome. Cleft Palate-Craniofacial J 43: 499-506, 2006.

Tanaka E, Suzuki O, Oh RJ, Takeda T, Teshima T, Inoue To, Inoue T. Intracavitary brachytherapy for carcinoma of the uterine cervix ―comparison of HDR(Ir-192) and MDR(Cs-137)―. Radiat Med 24: 50-57, 2006. [Pubmed]

Yamamoto G, Maoka K, Yamamoto T, Sakamoto K, Nishikawa M, Inoda H, Shimizutani K. A Patients with Tongue/Oral Floor Cancer who responded to Chemotherapy and High-Dose-Rate divided Tissue Irradiation. Oral Oncology 11: 121-123, 2006.

Yamazaki H, Nishiyama K, Tanaka E, Koizumi M, Chatani M. Radiotherapy for early glottic carcinoma (T1N0M0): results of prospective randomized study of radiation fraction size and overall treatment time. Int J Radiat Oncol Biol Phys 64: 77-82, 2006. [Pubmed]

Yoshida K, Nose T, Shiomi H, Yoshioka Y, Fujita Y, Kuroda S, Yoshida M, Takahashi T, Kitamura M, Akai H, Oka T, Hosoki T. New ambulatory implant technique of high-dose-rate interstitial brachytherapy for prostate cancer. Radiat Med 24: 595-599, 2006. [Pubmed]

Yoshioka Y, Konishi K, Oh RJ, Sumida I, Yamazaki H, Nakamura S, Nishimura K, Nonomura N, Okuyama A, Inoue T. High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer. Radiother Oncol 80: 62-68, 2006. [Pubmed]

2005

Atagi S, Kawahara M, Tamura T, Noda K, Watanabe K, Yokoyama A, Sugiura T, Senba S, Ishikura S, Ikeda H, Ishizuka N and Saijo N: Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a Phase III trial of the Japan Clinical Oncology Group (JCOG9812). Jpn J Clin Oncol 35:195-201, 2005 [Pubmed]

Hoshi M, Araki N, Naka N, Koizumi M, Hashimoto N, Onishi M, Sugiyasu K, Kimura N, Mori S, Nishiyama K, Yoshikawa H: Bone metastasis of intracranial meningeal hemangiopericytoma. Int J Clin Oncol 10:208-13, 2005 [Pubmed]

Iwakawa M, Goto M, Noda S, Sagara M, Yamada S, Yamamoto N, Kawakami Y, Matsui Y, Miyazawa Y, Yamazaki H, Tsuji H, Ohno T, Mizoe J, Tsujii H, Imai T: DNA repair capacity measured by high throughput DNA repair capacity measured by high throughput alkaline comet assays in EBV-transformed cell lines and peripheral blood cells from cancer patients and healthy volunteers. Mutat Res 588:1-6, 2005 [Pubmed]

Kenjo M, Oguchi M, Gomi K, Yamashita T, Uno T, Hirokawa Y, Inoue T, Teshima T: Radiation therapy for esophageal cancer: Results of the Patterns of Care Study in Japan 1995-1997. Esophagus 2:77-83, 2005

Mitsumori M, Hiraoka M, Negoro Y, Yamauchi C, Shikama N, Sasaki S, Yamamoto T, Teshima T, Inoue T: The Patterns of Care Study for breast-conserving therapy in Japan: Analysis of process survey from 1995 to 1997. Int J Radiat Oncol Biol Phys 62:1048-1054, 2005 [Pubmed]

Morizane C, Okusaka T, Ito Y, Ueno H, Ikeda M, Takezako Y, Kagami Y, Ikeda H: Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients. Oncology 68:432-437, 2005 [Pubmed]

Nose T, Koizumi M, Yoshida K, Nishiyama K, Sasaki J, Ohnishi T, Peiffert D: In vivo dosimetry of high-dose-rate brachytherapy: study on 61 head-and-neck cancer patients using radiophotoluminescence glass dosimeter. Int J Radiat Oncol Biol Phys 61:945-953, 2005 [Pubmed]

Ogata T, Teshima T, Kagawa K, Hishikawa Y, Takahashi Y, Nojima K, Furusawa Y, Matsuura N: Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 65:113-120, 2005 [Pubmed]

Ogawa K, Nakamura K, Onishi H, Teshima T: Radical external beam radiotherapy for clinically localized prostate cancer in Japan: Changing trends in the Patterns of Care Process Survey between 1996-1998 and 1999-2001. Anticancer Res 25:3507-3512, 2005 [Pubmed]

Ogawa K, Nakamura K, Sasaki T, Yamamoto T, Koizumi M, Inoue T, Teshima T, and the Japanese Patterns of Care Study Working Subgroup on Prostate Cancer: Radical external beam radiotherapy for prostate cancer in Japan: Preliminary results of the changing trends in the Patterns of Care Process Survey between 1996-1998 and 1999-2001. Jpn J Clin Oncol 34:131-136, 2004

[Pubmed]

Schlaefer A, Fisseler J, Dieterich S, Shiomi H, Cleary K, Schweikard A: Feasibility of four-dimensional conformal planning for robotic radiosurgery. Med Phys 32:3786- 3792, 2005 [Pubmed]

Schweikard A, Shiomi H, Adler J: Respiration tracking in radiosurgery without fiducials. Int J Medical Robotics and Computer Assisted Surgery 1:19-27, 2005

Schweikard A, Shiomi H, Adler J: Respiration tracking in radiosurgery: Med Phys 31:2738-41, 2004 [Pubmed]

Shimizutani K, Inoue T, Inoue T, Yoshioka Y, Kakimoto N, Murakami S, Furukawa S, Fuchihata H, Teshima T: Late complications after high-dose-rate interstitial brachytherapy for tongue cancer. Oral Radiol 21:1-5, 2005

Teshima T, Japanese PCS Working Group: Patterns of Care Study in Japan. Jpn J Clin Oncol 35:497-506, 2005 [Pubmed]

Toita T, Nakamura K, Uno T, Kodaira T, Shinoda A, Ogawa K, Mitsuhashi N, Maebayashi K, Kawaguchi A, Inoue T, Teshima T, Japanese PCS Working Group of uterine cervix cancer: Radiotherapy for uterine cervical cancer: Results of the 1995-1997 Patterns of Care Process Survey in Japan. Jpn J Clin Oncol 35:139-148, 2005 [Pubmed]

Uchiyama Y, Murakami S, Kakimoto N, Nakatani A, Furukawa S: Effectiveness of Cepharanthin in decreasing interruptions during radiation therapy for oral cancer. Oral Radiol 21:41-44, 2005

Yamazaki H, Inoue T, Tanaka E, Isohashi F, Koizumi M, Shuo X, Nakamura H, Inoue T: Pelvic irradiation-induced eosinophilia is correlated to prognosis of cervical cancer patients and transient elevation of serum interleukin 5 level. Radiat Med 23:317-321, 2005 [Pubmed]

Yamazaki H, Inoue T, Koizumi M, Tanaka E, Yoshioka Y, Nakamura H, Shuo X, Inoue T: Urinary 8-hydroxy-2'-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy. Oncol Rep 13:847-851, 2005 [Pubmed]

Yonemori K, Sumi M, Fujimoto N, Ito Y, Imai A, Kagami Y, Ikeda H: Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation. Cancer 104:811-816, 2005 [Pubmed]

Yoshida K, Nose T, Watanabe Y, Tokuda Y, Choi S, Hosoki T, Mitomo M, Inaba O, Iida T, Okada H: Quantitative evaluation of acute mucosal reaction to interstitial brachytherapy using color histograms. Brachytherapy 4:298-303, 2005 [Pubmed]

Yoshioka Y, Nishimura T, Kamata M, Harada H, Kanazawa K, Fuji H, Murayama S: Evaluation of anatomy-based dwell position and inverse optimization in high-dose-rate brachytherapy of prostate cancer: A dosimetric comparison to a conventional cylindrical dwell position, geometric optimization, and dose-point optimization. Radiother Oncol 75:311-317, 2005 [Pubmed]

Takahashi Y, Kozuka T, Gomi K, Tahara T, Yonese J, Okubo Y, Fukui I, Yamashita T. I-125 permanent implant brachytherapy. Jpn J Med Phys 25 (supp. 3-1): 32-35, 2005.

2004

Yamazaki H, Inoue T, Yoshida K, Tanaka E, Yoshioka Y, Nakamura H, Furukawa S, Shimizutani K, Kakimoto N, Inoue T: Lymph Node Metastasis of early oral tongue cancer after interstitial radiotherapy. Int J Radiat Oncol Biol Phys 58(1):139-146, 2004. [Pubmed]

Yamada Y, Shiomi H, Sumida I, Suzuki O, Isohashi F, Oh R-J, Tanaka E, Inoue Ta, Nakamura H: Quantitative evaluation of changes in irradiated lung fields after stereotactic irradiation by the Polygon Method. Radiat Med 22(2):98-105, 2004. [Pubmed]

Sumida I, Shiomi H, Oh R-J, Tanaka E, Isohashi F, Inoue Ta, Inoue To: An optimization algorithm of dose distribution using attraction-repulsion model (application to low-dose-rate interstitial brachytherapy). Int J Radiat Oncol Biol Phys 59(4):1217-1223, 2004. [Pubmed]

Yoshioka Y, Yamazaki H, Yoshida K, Ozeki S, Inoue T, Yoneda M, Inoue T: Impact of mitochondrial DNA on radiation sensitivity of transformed human fibroblast cells: Clonogenic survival, micronucleus formation and cellular ATP level. Radiat Res 162:143-147, 2004. [Pubmed]

Ishii, H, Furuse, J, Nagase, M, Yoshino, M, Kawashima, M, Satake, M, Ogino, T, Ikeda, H.: Hepatic arterial infusion of 5-fluorouracil and extrabeam radiotherapy for liver metastases from pancreatic carcinoma. Hepato-Gastroenterology 2004;51:1175-78.

Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, Shioyama Y, Inoue T; Japanese PCS Working Subgroup of Prostate Cancer. Radiotherapy for localized hormone-refractory prostate cancer in Japan. Anticancer Res 24:3141-5, 2004

Nose T, Koizumi M, Nishiyama K: High-dose-rate interstitial brachytherapy for oropharyngeal carcinoma: results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 59(4):983-991, 2004

Nose T, Peiffert D, Lapeyre M, Hoffstetter S, Koizumi M, Nishiyama K: Late effects of post-high-dose-rate brachytherapy for oropharyngeal carcinoma: Are they severer than post-low-dose-rate? Strahlenther Onkol 180(12):776-782, 2004

Ogawa K, Nakamura K, Sasaki T, Yamamoto T, Koizumi M, Teshima T, Inoue T, and the Japanese Patterns of Care Study Working Subgroup on Prostate Cancer. Radical external beam radiotherapy for prostate cancer in Japan: Preliminary results of the 1999-2001 Patterns of Care Process Survey. Jpn J Clin Oncol 34(1): 29-36, 2004

Ogawa K, Nakamura K, Sasaki T, Yamamoto T, Koizumi M, Inoue T, Teshima T, and the Japanese Patterns of Care Study Working Subgroup on Prostate Cancer. Radical external beam radiotherapy for prostate cancer in Japan: Preliminary results of the changing trends in the Patterns of Care Process Survey between 1996-1998 and 1999-2001. Jpn J Clin Oncol 34(3): 131-136, 2004

Okusaka, T, Ito, Y, Ueno, H, Ikeda, M, Takezaka, Y, Morizane, C, Kagami, Ikeda, H: Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer. Brit J Cancer 2004;91:673-677.

Achim Schweikard, Hiroya Shiomi, John Adler; Respiration tracking in radiosurgery; Medical Physics Volume 31, Issue 10, pp. 2738-2741

Sekiguchi N, Nishimoto J, Tanimoto K, Kusumoto S, Onishi Y, Watanabe T, Kobayashi Y, Asamura H, Kagami Y, Matsuno Y, Tobinai K. Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan. Int J Hematol 79:465-471,2004

Toita T, Mitsuhashi N, Teshima T, Maebayashi K, Nakamura K, Takahashi Y, Inoue T, and the Japanese PCS Working Subgroup for Uterine Cervical Cancer. Postoperative radiotherapy for uterine cervical cancer: Results of the 1995-1997 Patterns of Care Process Survey in Japan. Jpn J Clin Oncol 34(2): 99-103, 2004

Yamazaki H, Hanada M, Horiki M, Kuyama J, Sato T, Nishikubo M, Ishida T, Inoue T: Acute tumor lysis syndrome caused by palliative radiotherapy in patients with diffuse large B-cell lymphoma. Radiat Med 22: 52-5, 2004

Yoshida K, Inoue T, Inoue T, Tanaka E, Shiomi H, Teshima T: Treatment results of radiotherapy with or without surgery for posterior pharyngeal wall cancer of oropharynx and hypopharynx: prognostic value of tumor extension. Radiat Med 22:30-6,2004

Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, Shioyama Y, Inoue T. Radiotherapy for Localize Hormone-refractory Prostate Cancer in Japan. Anticancer Res. 24: 3141-3146, 2004.

Takahashi Y, Ito A, Yamashita T. Verification of Accuracy of Dose Calculation of RTP Systems of High Dose Rate Brachytherapy by Monte Carlo Simulation. Proc EGS4 Meeting. 74-80, 2004.

Toita T, Mitsuhashi N, Teshima T, Maebayashi K, Nakamura K, Takahashi Y, TInoue. Postoperative Radiotherapy for Uterine Cervix Cancer: Results of the 1995-1997 Patterns of Care Process Survey in Japan. Jpn J Clin Oncol. 34(2): 99-103, 2004. [Pubmed]

2003

Kakimoto N, Inoue T, Inoue T, Murakami S, Furukawa S, Yoshida K, Yoshioka Y, Yamazaki H, Tanaka E, Shimizutani K: Results of low- and high-dose-rate interstitial brachytherapy for T3 mobile tongue cancer. Radiotherapy Oncology 68(2): 123-128, 2003. [Pubmed]

Koizumi M, Yamazaki H, Toyokawa K, Ozeki S, Matsumura S, Inoue T, Inoue T: Influence of in vitro radiation on changes in nitric oxide in rat macrophagas and smooth muscle cells. Anticancer Research 23(1A): 331-334, 2003. [Pubmed]

Matsumura S, Matsumura T, Ozeki S, Fukushima S, Yamazaki H, Inoue T, Inoue T, Furusawa Y, Eguchi-Kasai K: Comparative analysis of G2 arrest after irradiation with 75 keV carbon-ion beams and 137Cs gamma-rays in a human lymphoblastoid cell line. Cancer Detect Prev 27(3):222-228, 2003. [Pubmed]

Tanaka E, Oh R-J, Yamada Y, Shiomi H, Nakamura S, Shimamoto S, Teshima T, Inoue T, Inoue T: Prospective study of HDR(Ir-192) versus MDR(Cs-137) intracavitary brachytherapy for carcinoma of the uterine cervix. Brachytherapy 2:85-90, 2003. [Pubmed]

Yamazaki H, Hanada M, Kitada M, Kuyama J, Sato T, Nishikubo M, Ishida T, Inoue T, Inoue T: Four Cases of Central Nervous System Involvement of Breast Malignant Lymphoma. Jpn J Clin Oncol 33(8):399-403,2003. [Pubmed]

Yamazaki H, Inoue T, Yoshida K, Yoshioka Y, Furukawa S, Kakimoto N, Shimizutani K, Inoue T: Brachytherapy for early oral tongue cancer: low dose rate to hig dose rate. J Radiat Res. 44(1):37-40, 2003. [Pubmed]

Yoshioka Y, Nose T, Yoshida K, Oh R-J, Yamada Y, Tanaka E, Yamazaki H, Inoue T, Inoue T:High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys 56(1):213-220, 2003. [Pubmed]

Ikeda, H: Special report: Non-invasive management of invasive bladder cancer:Lectures by Professor William U. Shipley. Jpn J Clin Oncol 2003;33:592-594.

Takahashi Y, Teshima T, Kawaguchi N, Hamada Y, Ogata T, Ikeda S, Mizuno H, Nojima K, Furusawa Y, Matsuura N. Heavy Ion Irradiation Inhibits in Vitro Angiogenesis even at Sublethal Dose. Cancer Res. 63: 4253-4257, 2003. [Pubmed]

Nakamura K, Teshima T, Takahashi Y, Imai A, Koizumi M, Mitsuhashi N, Inoue T. Radical Radiation Therapy for Prostate Cancer in Japan: Patterns of Care Study Report. Jpn J Clin Oncol. 33: 122-126, 2003. [Pubmed]

Sugiyama H, Teshima T, Ohno Y, Inoue T, Takahashi Y, Oshima A, Sumi M, Uno T, Ikeda H, and PCS Working Subgroup for Lung Cancer. The Patterns of Care Study and Regional Cancer Registry of Non-Small Cell Lung Cancer in Japan. Int J Radiat Oncol Biol Phys. 56(4), 1005-1012, 2003. [Pubmed]

Gomi K, Oguchi M, Hirokawa Y, Kenjo M, Ogata T, Takahashi Y, Nakamura N, Yamashita T, Teshima T, Inoue T. Process and preliminary outcome of a patterns-of-care study of esophageal cancer in Japan: Patients treated with surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 56(3): 813-822, 2003. [Pubmed]

2002

Yamazaki H, Yoshioka Y, Inoue Ta, Tanaka E, Nishikubo M, Sato T, Ishida T, Nakamura H, Inoue To: Changes in natural killer cell activity by external radiotherapy and/or brachytherapy. Oncology Reports 9:359-363, 2002

Yamazaki H, Tomoda K, Shiomi H, Maeda M, Kawata S, Okada A, Murakami T, Nakamura H, Inoue Ta, Inoue To: High dose rate endovascular brachytherapy in aorto-iliac lesion for the prevention of restenosis. Radiation Medicine 20(1): 25-32, 2002. [Pubmed

Uno T., Sumi M., Ikeda H., Teshima T., Yamashita M., Inoue T., and Japanese PCS Working Subgroup for Lung Cancer: Radiation therapy for small-cell lung cancer: results of the 1995-1997 patterns of care process survey in Japan. Lung Cancer 35: 279-285, 2002. [Pubmed]

Shikama N, Sasaki S, Mitsumori M, Hiraoka M, Yamamoto T, Teshima T, Inoue T: - Patterns of Care Study in Japan -, Analysis of patients subjected to mastectomy followed by radiotherapy. Proceedings of the 12th Japan-Korea Radiology Congress, p.46, 2002.

Inoue T.: Establishment of clinical QA of radiotherapy through PCS in Japan. 4th Shanghai International Conference on Radiation Oncology. Pp.9-11, 2002.

Tanaka E, Oh R-J, Yamada Y, Yoshioka Y, Inoue Ta, Inoue To: High dose rate hyperfractionated interstitial brachytherapy for uterine cervical cancer. Proceedings of 23rd Annual Meeting of American Brachytherapy Society (ABS). p.57, 2002.

Tanisada K., Teshima T., Ohno Y., Inoue T., Abe M., Ikeda H., Owen J.B., Hanks G.E., Masuda K., Honke Y., and Japanese PCS 1992-1994 Working Group: Patterns of Care Study quantitative evaluation of the quality of radiotherapy in Japan. Cancer, 95(1): 164-171, 2002. [Pubmed]

Shimamoto S, Inoue T, Shiomi H, Sumida I, Yamada Y, Tanaka E, Inoue T: CyberKnife stereotactic irradiation for metastatic tumors. Radiation Medicine 20(6): 299-304, 2002. [Pubmed]

Yamamoto T, Teshima T, Miyajima S, Matsumoto M, Shiomi H, Inoue T, Inoue T, Hirayama H: Monte Carlo calculation of depth doses for small field of CyberKnife. Radiation Medicine 20(6): 305-310, 2002. [Pubmed]

Yamazaki H, Oi H, Matsushita M, Inoue T, Nakamura H, Inoue T: Renal cortical retention of contrast medium on delayed CT and nephropathy following transcatheter arterial chemoembolisation in patients with high serum creatinine level. British Journal of Radiology 75: 874-878, 2002. [Pubmed]

2001

Yamazaki H, Inoue Ta, Yoshida K, Imai, A, Yoshioka Y, Tanaka E, Shimamoto S, Nakamura S, Yamada Y, Nakamura H, Araki Y, Inoue To: Changes in performance status of elderly patients after radiotherapy. Radiation Medicine, 19(1):9-18,2001. [Pubmed]

Yamazaki H, Inoue Ta, Yoshida K, Imai, A, Yoshioka Y, Tanaka E, Shimamoto S, Nakamura S, Inoue To, Nakamura H, Furukawa S, Shimizutani K: Influence of age on the results of brachytherapy for early tongue cancer. Int J Radiat Oncol Biol Phys, 49(4):931-936,2001. [Pubmed]

Yoshida K, Yamazaki H, Ozeki S, Inoue Ta, Yoshioka Y, Yoneda M, Fujiwara Y, Inoue To: Mitochondrial genotypes and radiation-induced micronucleus formation in human osteosarcoma cells in vitro. Oncology Reports, 8:615-619, 2001.

Imai A, Teshima T, Ohno Y, Inoue T, Yamashita T, Mitsuhashi N, Hiraoka M, Sumi M and the Japanese PCS Working Group: The future demand for and structural problems of Japanese radiotherapy. Jpn J Clin Oncol, 31(4):135-141, 2001. [Pubmed]

Koizumi M, Yamazaki H, Toyokawa K, Yoshioka Y, Suzuki G, Ito M, Shinkawa K, Nishino K, Watanabe Y, Inoue Ta, Inoue To: Influence of thoracic radiotherapy on exhaled nitric oxide levels in patients with lung cancer. Jpn J Clin Oncol, 31(4):142-146, 2001. [Pubmed]

Hayashi M, Teshima T, Tanisada K, Ohno Y, Inoue T, Hiraoka M, Yamashita T, Mitsuhashi N, Sumi M, and Japanese PCS Working Group: Automatic search for optimal conditions in clinical studies. Anticancer Research, 21:1371-1374, 2001. [Pubmed]

Inoue T: Perioperative high dose rate brachytherapy for soft tissue sarcoma. Jpn J Clin Oncol, 31(6): 237-239, 2001. [Pubmed]

Inoue Ta, Inoue To, Yoshida K, Yoshioka Y, Shimamoto S, Tanaka E, Yamazaki H, Shimizutani K, Teshima T, Furukawa S.: Phase III trial of high- vs. low-dose-rate interstitial radiotherapy for early mobile tongue cancer. Int J Radiat Oncol Biol Phys 51: 171-175, 2001. [Pubmed]

Inoue T: MicroSelectronHDR brachytherapy at the Osaka University for this 10 years. Osaka University Hospital: Ir-192 Brachytherapy 10th Anniversary. Pp. 12-14, 2001.

Yamazaki H, Oi H, Matsushita M, Kim T, Tanaka E, Inoue T, Nakamura H, Teshima T, Inoue T* Renal cortical retention on delayed CT and nephropathy following transcatheter arterial chemoembolization. The British Journal of Radiology 74: 695-700, 2001. [Pubmed]

Yoshioka Y, Yoshida K, Shimizutani K, Furukawa S, Inoue T, Teshima T, Yamazaki H, Tanaka E, Inoue T: Proposal of a new grading system for evaluation of tongue hemiatrophy as a late effect of a brachytherapy for oral tongue cancer. Radiotherapy and Oncology, 61:87-92, 2001. [Pubmed]

Yoshioka Y, Nose T, Yoshida K, Tanaka E, Inoue Ta, Inoue To: 3-Dimensional high-dose-rate brachytherapy as monotherapy for localized prostate cancer: 5-year experience of Osaka University. Proceedings of The 3rd Takahashi Memorial International Workshop on 3-Dimensional Conformal Radiotherapy (Nagoya). pp. 135, 2001.

Ohta H, Matsuda Y, Osugi Y, Fujisaki H, Tokimasa S, Maruno M, Yoshimine T, Inoue Ta, Inoue To, Hara J: Multimodal therapy for primary intracranial nongerminomatous malignant germ cell tumor in children and young adults. Int J Pediatric Hematology/Oncology 7(5-6): 385-390, 2001.

Shimizutani K, Koseki Y, Inoue To, Inoue Ta, Yoshida K, Kakimoto N, Murakami S, Furukawa S, Tanaka E: Interstitial brachytherapy for carcinoma of the tongue using microSelectron-HDR. Oral Radiol 17(2):95-101, 2001.

2000

Shiomi H, Inoue Ta, Nakamura S, Inoue To: Quality assurance for an image-guided frameless radiosurgery system using radiochromic film. Radiat. Med. 18(2):107-113, 2000. [Pubmed]

Tanisada K, Teshima T, Ikeda H, Abe M, Owen JB, Hanks GE, Yamashita T, Nishio M, Yamada S, Sakai K, Hiraoka M, Hirokawa Y, Oguchi M, Inoue T: A preliminary outcome analysis of the Patterns of Care Study in Japan for special reference to age: Non surgery group. Int. J. Radiat. Oncol. Biol. Phys. 46(5), 1223-1233, 2000. [Pubmed]

Yoshida K, Yamazaki H, Ozeki S, Inoue Ta, Yoshioka Y, Inoue To: Role of mitochondrial DNA in radiation exposure. Radiat. Med. 18(2):87-91, 2000. [Pubmed]

Kojima Y, Nonomura N, Nose T, Inoue T, Tsuda K, Narumi Y, Nakamura H, Shin M, Yasunaga Y, Aozasa K, Miki T, Okuyama A: Transitional zone biopsy in the detection of prostate cancer. Eur Urol, 37:675-679,2000. [Pubmed]

Inoue To, Inoue Ta, Teshima T: High dose rate interstitial brachytherapy for mobile tongue cancer: Part 1. Phase I/II study of HDR hyperfractionated interstitial brachytherapy for oral cancer. Jpn J Cancer Chemother, 27 (Suppl II):287-290, 2000.

Inoue To, Inoue Ta: High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 2. Phase III trial of HDR versus LDR interstitial brachytherapy for T1-T2N0 carcinoma of the mobile tongue. Jpn J Cancer Chemother, 27 (Suppl II):291-295, 2000.

Inoue To, Inoue Ta, Yoshioka Y, Yoshida K: High-dose rate interstitial brachytherapy for mobile tongue cancer: Part 3. Comparative study of early mucosal reaction and late tongue atrophy between LDR and HDR Ir-192 interstitial brachytherapy for patients with carcinoma of the mobile tongue. Jpn J Cancer Chemother, 27 (Suppl II):296-300, 2000.

Inoue To, Inoue Ta, Koizumi M, Yoshida K: Perioperative high-dose rate hyperfractionated brachytherapy for bone and soft tissue sarcomas. Jpn J Cancer Chemother, 27 (Suppl II):427-431, 2000.

Inoue T: Phase III study of HDR versus LDR interstitial brachytherapy for early carcinoma of the mobile tongue. in Innovative Radiotherapy Technologies. Yonsei International Radaition Oncology Symposium 2000, pp.47-52, 2000.

Inoue T: The CyberKnife treatment for intracranial and head and neck cancer. in Innovative Radiotherapy Technologies. Yonsei International Radaition Oncology Symposium 2000, pp.93-98, 2000.

Inoue To, Inoue Ta, Yoshida K, Shimamoto S, Yamazaki H: Phase III trial of HDR versus LDR interstitial brachytherapy as monotherapy for early carcinoma of the mobile tongue. Radiother Oncol, 55(Suppl.1):19-20, 2000.

Yoshioka Y, Nose T, Yoshida K, Inoue Ta, Yamazaki H, Tanaka E, Shiomi H, Imai A, Nakamura S, Shimamoto S, Inoue To: Hyperfractionated high dose rate interstitial brachytherapy as monotherapy for localized prostate cancer. Radiother Oncol, 55(Suppl.1):76, 2000.

Yamashita T, Honda C, Fukuda I, Akagi Y, Kenjo M, Teshima T, Inoue To, Tanisada S, Japanese PCS Working Group: Patterns of care study for esophageal cancer in Japan: Process survey (1995-1997) with special reference to brachytherapy. Radiother Oncol, 55(Suppl.1):87, 2000.

Yamazaki H, Yoshida K, Yoshioka Y, Inoue T, Ozeki S, Inoue T: Mitochondrial genotypes and radiation-induced micronucleus formation in human osteosarcoma cells in vitro. Radiother Oncol 56 (Suppl 1):S111, 2000.

Shimizutani K, Koseki Y, Inoue To, Inoue Ta, Yoshida K, Teshima T, Furukawa S, Fuchihata H, Tanaka Y: Effectiveness of radiation combined with peplomycin as an induction therapy for carcinoma of the oral cavity. in Oral and Maxillofacial Radiology Today. edited by H. Fuchihata et al., Elsevier B.V. pp. 29-36, 2000.

Yoshioka Y, Nose T, Yoshida K, Inoue Ta, Yamazaki H, Tanaka E, Shiomi H, Imai, A, Nakamura S, Shimamoto S, Inoue To: High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary result of a phase I/II clinical trial. Int J Radiation Oncology Biol Phys, 48(3): 675-681, 2000. [Pubmed]

Yamazaki H, Inoue Ta, Tanaka E, Yoshida K, Imai, A, Yoshioka Y, Nakamura H, Yoshida J, Inoue To: Radiation and low dose adriamycin for the treatment of carcinoma of the hypopharynx. Anticancer Research, 20:4713-4720, 2000. [Pubmed]

Delclos L, Dinshaw K, Gerbaulet A, Inoue T, Pinilla J, Tahir A, Uribe J: IAEA-ARBR-2000-02. The role of long half-life isotopes for use in LDR brachytherapy. Report of the Advisory Group Meeting (325-E3-AG-1086). IAEA, Vienna, 2000. 8.

Yamamoto M, Doki Y, Shiozaki H, Yano M, Miyata H, Tamura S, Fujiwara Y, Yasuda T, Tanaka E, Inoue T, Monden M: Evaluation of the histologic effect of chemoradiation therapy for squamous cell carcinomas of the esophagus by assessing morphologic features of surgical specimens. Diseases of the esophagus, 13:293-300, 2000. [Pubmed]

Yoshida K, Nakamura S, Yoshioka Y, Koizumi M, Tanaka E, Imai A, Shiomi H, Shimamoto S, Yamazaki H, Inoue Ta, Inoue To, Sawada T: High dose rate hyperfractionated interstitial brachytherapy for squamous cell carcinoma of the external nose. J Brachytherapy Int, 16:263-270, 2000.

1999

Teshima, T., Ikeda, H., Abe, M., Hanks, J.E., Owen, J.E., Oguchi, M., Hirokawa, Y., Hiraoka, M., Nishio, M., Yamashita, T., Naito, A., Okazaki, Y., Inoue, T.: Patterns of Care Study of radiation therapy for uterine cervix cancer in Japan. The influence of age on the process. Int. J. Clin. Oncol. 4:9-16,1999.

Fukushima, S., Inoue, To., Inoue, Ta., Ozeki, S.: Postoperative irradiation of pterygium with 90Sr eye applicator. Int. J. Radiat. Oncol. Biol. Phys. 43(3): 597-600,1999. [Pubmed]

Koizumi, M., Inoue, Ta., Yamazaki, H., Teshima, T., Tanaka, E., Yoshida, K., Imai, A., Shiomi, H., Kagawa, K., Araki, N., Kuratsu, S., Uchida, A., Inoue, To.: Perioperative fractionated high-dose rate brachytherapy for malignant bone and soft tissue tumors. Int. J. Radiat. Oncol. Biol. Phys. 43(5): 989-993,1999. [Pubmed]

Inoue, To., Inoue, Ta., El-Baradie, M.M., Teshima, T., Chatani, M.: HDR brachytherapy for carcinoma of the uterine cervix: 25-year clinical study in Osaka. Japan/U.S. Cancer Therapy Symposium in Hiroshima, pp. 59-61,1999.

Mitsumori, M., Hiraoka, M., Negoro, Y., Nihei, K., Shikama, N., Sasaki, S., Teshima, T., Inoue, T.: The Patterns of Care Study for early breast cancer in Japan. Japan/U.S. Cancer Therapy Symposium in Hiroshima, p. 83,1999.

Chatani, M., Nishiyama, K., Nose, T., Koizumi, M., Teshima, T., Inoue, Ta., Inoue, To.: High-dose rate intracavitary irradiation for carcinoma of the uterine cervix: The adverse effect of treatment prolongation. Japan/U.S. Cancer Therapy Symposium in Hiroshima, p. 85,1999.

Tanisada, K., Teshima, T., Uchida, M., Ikeda, H., Abe, M., Owen, J.B,, Hanks, G.E., Yamashita, T., Nishino, M., Yamada, S., Sakai, K., Hiraoka, M., Hirokawa, Y., Oguchi, M., Inoue, T.: A preliminary outcome analysis of Patterns of Care Study in Japan for cervix cancer patients with special reference to age. Japan/U.S. Cancer Therapy Symposium in Hiroshima, p. 88,1999.

Tanisada, K., Teshima, T., Inoue, T., Owen, J.B,, Hanks, G.E., Abe, M., Ikeda, H., Sato, S., Kawachi, K., Yamashita, T., Nishio, M., Hiraoka, M., Hirokawa, Y., Oguchi, M., Masuda, K.: National average for the process of radiation therapy in Japan by Patterns of Care Study. Jpn J Clin Oncol. 29(4): 209-213,1999. [Pubmed]

El-Baradie, M.M., Fournier-Bidoz, N., Inoue, To., Inoue, Ta., Yamazaki, H.: Volume analysis of medium dose rate and high dose rate brachytherapy for carcinoma of the uterine cervix. J. Brachytherapy Int. 15: 13-25,1999.

El-Baradie, M.M. , Yamazaki, H., Inoue, To., Inoue, Ta., Koizumi, M.: Clinical implication of volume and isodose curve in the outcome of high dose rate and medium dose rate brachytherapy for carcinoma of the uterine cervix. J. Brachytherapy Int. 15: 93-103, 1999.

Matsumura, S., Jikko, A., Ozeki, S., Tang, J-T, Fukushima, S., Yamazaki, H., Inoue, Ta., Hatanaka, K., Inoue, To., Fuchihata, H.: Differences in the biological effects of in vitro irradiation by 65 MeV protons and 137Cesium g-rays. Anticancer Research, 19: 477-480, 1999. [Pubmed]

Inoue, To., Inoue, Ta., Shiomi, H.: Preliminary experience of new stereotactic radiotherapy system using robot and tracking method (Cyberknife): Proceedings of the 9th workshop of the German-Japanese Radiological Affiliation. p.190, 1999.

Yoshida, K., Koizumi, M., Inoue, Ta., Yamazaki, H., Imai, A., Shiomi, H., Yoshioka, Y., Tanaka, E., Shimizutani, K., Furukawa, S., Inoue, To.: Radiotherapy of early tongue cancer in patients less than 40 years old. Int. J. Radiat. Oncol. Biol. Phys. 45(2): 367-371,1999. [Pubmed]

Inoue, T., Teshima, T., Yamashita, T., Hiraoka, M., Mitsuhashi, N., Sumi, M., Tanisada, K., Japanese PCS Working Group, Owen, J.B., Hanks, G.E.: The Patterns of Care Study in Japan: A preliminary analysis of process survey from 1995 to 1997. Proceedings of the ASTRO 41st Annual Meeting, Int J Radiat Oncol Biol Phys, 45(3, Suppl), 400, 1999.

Yoshida, K., Shimizutani, K., Tanaka, E., Shiomi, H., Yamazaki, H. Imai, A., Yoshioka, Y., Nakamura, S., Inoue, Ta., Inoue, To.: Ultrasonographic monitoring of high dose rate interstitial implant using template technique for oral tongue cancer. Radiation Medicine, 17(5): 337-341, 1999. [Pubmed]

Inoue, Ta., Yamazaki, H., Inoue, To.: Brachytherapy for head and neck cancer. Program & Abstracts of International Symposium of Future Development on Radiation Oncology '99, pp. 68-69, 1999.

Inoue, To., Inoue, Ta., Tanaka, E., Yamazaki, H., Yoshida, K., Shiomi, H., Imai, A., Yoshioka, Y., Nakamura, S.: High dose rate fractionated interstitial brachytherapy as the sole treatment for recurrent carcinoma of the uterus. J., Brachytherapy Int, 15:161-167, 1999.

Tang, J-T., Yamazaki, H., Inoue, Ta., Koizumi, M., Yoshida, K., Ozeki, S., Inoue, To.: Mitochondrial DNA influences radiation sensitivity and induction of apoptosis in human fibroblasts. Anticancer Research, 19:4959-4964,1999. [Pubmed]

Kai, J., Shiomi, H., Sasama, T., Sato, Y., Inoue, Ta., Tamura, S., Inoue, To. A 3D optical head motion measurement system and its application in stereotactic radiosurgery. Medical Imaging Technology, 17(2): 155-164,1999

1998

Inoue, T., Inoue, To., Yamazaki, H., Koizumi, M., Kagawa, K., Yoshida, K., Shiomi, H., Imai, A., Shimizutani, K., Tanaka, E., Nose, T., Teshima, T., Furukawa, S., Fuchihata, H.: High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth. Int. J. Radiat. Oncol. Biol. Phys. 41(1): 53-58, 1998. [Pubmed]

Yamazaki, H., Inoue, Ta., Teshima, T., Tanaka, E., Koizumi, M., Kagawa, K., Imai, A., Yoshida, K., Shiomi, H., Schimizutani, K., Furukawa, S., Fuchihata, H., Nakamura, H., Inoue, To.: Tongue cancer treated with brachytherapy: Is thickness of tongue cancer a prognostic factor for regional control? Anticancer Research, 18: 1261-1266, 1998. [Pubmed]

El-Baradie, M..M., Fournier-Bidoz, N., Inoue, To., Inoue, Ta., Yamazaki, H.: Dose rate definition microSelectron-HDR and Selectron-MDR in brachytherapy for carcinoma of the cervix. Anticancer Research, 18: 2069-2076, 1998. [Pubmed]

Teshima, T., Abe, M., Ikeda, H., Hanks, G.E., Owen, J.B., Hiraoka, M., Hirokawa, Y., Oguchi, M., Nishio, M., Yamashita, T., Niibe, H., Masuda, K., Watanabe, S., Inoue, T.: Patterns of care study of radiation therapy for esophageal cancer in Japan. Influence of the stratification of institution on the process. Jpn. J. Clin. Oncol. 28(5): 308-313, 1998. [Pubmed]

Yamazaki, H., Tang, J-T, Koizumi, M., Kagawa, K., Inoue, Ta., Imai, A., Yoshida, K., Shiomi, H., Tanaka, E., Nakamura, H., Inoue, To.: 5 Gy irradiation does not alter the expression level of WTl (Wilms Tumor Gene) in K562 and MLl. Anticancer Research, 18: 2495-2498,1998. [Pubmed]

Koizumi, M., Fujii, J., Suzuki, K., Inoue, Ta., Inoue, To., Gutteridge, J.M.C., Taniguchi, N.: A marked increase in free copper levels in the plasma and liver of LEC rats. An animal model for Wilson Disease and liver cancer. Free Rad. Res. 28: 441-450, 1998.

Nishino, T., Teshima, T., Abe, M., Ikeda, H., Oguchi, M., Hirokawa, M., Hiraoka, M, Inoue, T., Yamashita, T., Nishio, M., Niibe, H., Mori, T., Masuda, K., Harauchi, H., Inamura, K.: Consistency of variables in PCS and JASTRO Great Area Database. Radiation Medicine, 16(6): 449-455, 1998. [Pubmed]

Tanisada, K., Teshima, T., Ikeda, H., Abe, M., Yamashita, T., Nishio, M., Inoue, T., Hiraoka, M., Hirokawa, M., Yamada, S., Sakai, K., Nishimura, T., Chatani, M.: Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS. A preliminary study. Radiation Medicine, 16(6): 461-468,1998. [Pubmed]

El-Baradie, M..M., Fournier-Bidoz, N., Inoue, To., Inoue, Ta., Yamazaki, H.: Brachytherapy dose specification for carcinoma of the uterine cervix, I: Medium dose rate. J. Brachytherapy Intl. 14: 83-95,1998.

El-Baradie, M.M., Fournier-Bidoz, N., Inoue, To., Inoue, Ta., Koizumi, M.: Brachytherapy dose specification for carcinoma of the uterine cervix, II: High dose rate. J. Brachytherapy Intl. 14: 97-106,1998.

Chatani, M., Nose, T., Masaki, N., Inoue, T.: Adjuvant radiotherapy after radical hysterectomy of the cervical cancer. Strahlenther. Onkol. 174 (10): 504-509,1998. [Pubmed]

Inoue, To., Inoue, Ta., El-Baradie, M., Teshima, T., Chatani, M.: HDR brachytherapy in treatment of cancer of the uterine cervix: Osaka Experience. in Brachytherapy for the 21st Century. Edited by BL Speiser and RF Mould, Nucletron B.V., Veenendaal, The Netherlands, pp. 246-253,1998.

1997

Tang, J-T., Inoue, To., Inoue, Ta., Matsumura S., Fukushima, S., Koizumi, M., Ozeki, S., Hatanaka, K.: Differences in repair of potentially lethal damage in Chinese hamster ovary cells exposed to 65 MeV proton beams and 137Cesium g-rays. Oncology Reports, 4: 407-412,1997.

Fukushima, S., Ozeki, S., Tang, J-T., Koizumi, M., Matsumura, S., Inoue, Ta., Inoue, To., Yamazaki, H., Murayama, S., Hatanaka, K., Ejiri, H., Kasai, K.: Induction of p53 protein by carbon-ion and proton beam irradiation in two close human lymphoblastoid cell lines with different p53 status. Oncology Reports, 4: 481-484,1997.

Yamazaki, H., Inoue, Ta., Tang, J-T., Nose, T., Koizumi, M., Tanaka, E., Teshima, T., Ozeki, S., Nakamura, H., Inoue, To.: Lack of effect of hepatocyte growth factor on bone marrow suppression induced by total body irradiation in the rat. Anticancer Research, 17: 479-480,1997. [Pubmed]

El-Baradie, M., Inoue, To., Inoue, Ta., Murayama, S., Tang, J-T., Yamazaki, H., Fournier-Bidoz, N.: HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study. Strahlenther Onkol, 173(3): 155-162,1997. [Pubmed]

Yamazaki, H., Oi, H., Matsushita, M., Inoue, Ta., Tang, J-T., Nose, T., Koizumi, M., Tanaka, E., Teshima, T., Ozeki, S., Nakamura, H., Inoue, To.: Heparin induces rapid and remarkable elevation of hepatocyte growth factor/scatter factor during trans-arterial embolization of renal cell carcinoma. Anticancer Research, 17: 1435-1438,1997. [Pubmed]

Jingu K, Ohmagari J, Masuda K, Morita K, Sakamoto K, Niibe H, Ishigaki T, Takashima T, Inoue T, Nakao N, Ito K, Matsunaga N, Yoshida S, Hayabuchi N, Nakajo M, Yoshimura T: Effect of OK-432 combined UFT in patient with stage III non-small cell lung cancer treated by radiotherapy. -A randomized prospective study-. J Jpn Soc Ther Radiol Oncol, 9(2): 115-124,1997.

Tang, JT, Inoue, T., Inoue, T., Yamazaki, H., Fukushima, S., Koizumi, M., Ozeki, S., Hatanaka, K.: Comparison of radiobiological effective depths in 65 MeV modulated proton beams. Brit. J. Cancer, 76(2): 220-225,1997. [Pubmed]

Fournier-Bidoz, N., Inoue, To., Inoue, Ta., Nose, T.: Use of the Anderson dose-volume histogram to evaluate interstitial implants. J. Brachytherapy Intl. 13: 235-242,1997.

Chatani, M., Matayoshi, Y., Masaki, N., Inoue, T.: High-dose rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation. Strahlenther. Onkol. 173(7): 379-384,1997. [Pubmed]

Yamazaki, H., Inoue, Ta., Koizumi, M., Yoshida, K., Kagawa, K., Shiomi, H., Nose, T., Tanaka, E., Teshima, T., Nakamura, H., Shimizutani, K., Furukawa, S., Fuchihata, H., Inoue, To.: Comparison of the long term results of brachytherapy for T1-2N0 oral tongue cancer treated with Ir-192 and Ra-226. Anticancer Research, 17: 2819-2822,1997. [Pubmed]

Koizumi, M., Inoue, T., Inoue, T., Yamazaki, H., Tang, J-T., Kagawa, K., Murayama, S., Nose, T., Tanaka, E., Shiomi, H.: Brachytherapy three-dimensional simulation modelling in clinical practice. Current Oncology, 4(1): 36-38,1997.

El-Baradie, M.M., Inoue, To., Inoue, Ta., Fournier-Bidoz, N.: High dose rate and medium dose rate brachytherapy for carcinoma of the uterine cervix: Five-year clinical experience of Osaka University Hospital. J. Brachytherapy Intl. 13(3): 261-269,1997.

Yamazaki, H., Oi, H., Matsushita, M., Inoue, T., Teshima, T., Koizumi, M., Nose, T., Tanaka, E.,, Nakamura, H., Inoue, T., Kim, T., El-Baradie, M.M.: Renal cortical retention on delayed CT after angiography and contrast associated nephropathy. Brit. J. Radiol. 70:897-902,1997. [Pubmed]

Yamazaki, H., Oi, H., Matsushita, M, Kim, T., El-Baradie, M., Inoue, Ta., Teshima, T., Koizumi,., M, Nose,T., Tanaka, E., Nakamura, H., Inoue, To.: Lack of correlation between gallbladder opacification in delayed CT and contrast-associated nephropathy. Eur. Radiol. 7:1328-1331,1997. [Pubmed]

Chatani, M., Matayoshi, Y., Masaki, N., Teshima, T., Inoue, To.: Radiation therapy for early glottic carcinoma (T1N0M0). The adverse effect of treatment interruption. Strahlenther Onkol, 173(10): 502-506,1997. [Pubmed]

Yamazaki, H., Takeuchi, E., Tang, J-T., Fukushima, S., Inoue, Ta., Shinkawa, K., Watanabe, Y., Tanaka, E., Teshima, T., Ozeki, S., Koizumi, M., Ito, M., Nakamura, H., Inoue, To.: Effects of thoracic irradiation on hepatocyte growth factor in rats lung and in bronchoalveolar lavage fluid of patients with thoracic malignancies. Euro. Resp. J. 10: 2539-2544, 1997. [Pubmed]

Kagawa, K., Inoue, T., Tokino, T., Nakamura, Y., Akiyama, T: Overexpression of GML promotes radiation-induced cell cycle arrest and apoptosis. Biochemical and Biophysical Research Communications, 241: 481-485, 1997. [Pubmed]

Yamazaki, H., Inoue, Ta., Koizumi, M., Yoshida, K., Kagawa, K., Shiomi, H., Imai, A., Tanaka, E., Teshima, T., Nakamura, H., Shimizutani, K., Furukawa, S., Fuchihata, H., Inoue, To.: Age as a prognostic factor for late local recurrence of early tongue cancer treated with brachytherapy. Anticancer Research, 17: 4709-4712, 1997. [Pubmed]

1996

Inoue, To., Nose, T., Inoue, Ta., Murayama, S., Tanaka, E., Inoue, H.: HDR interstitial brachytherapy for prostate cancer: Radiotherapy Treatment Planning, Proceedings of the 1st Far East Radiotherapy Treatment Planning Workshop. edited by F. Young, M. Gurtler, RF Mould, Nucletron-Oldelft, Veenendaal, The Netherlands, pp.133-138,1996.

Fukushima, S., Ozeki, S., Tang, J-T., Yamazaki, H., Matsumura, S., Inoue, Ta., Inoue, To., Murayama, S., Hatanaka, K., Hosono, K., Shimizu, A., Miura, I., Ejiri, H., Kanai, K.: Cell cycle kinetics and p53 protein induction in human lymphoblast cell lines following exposure to 65 MeV proton beam. RCNP Annual Report 1995, pp.67-69,1996.

Okawa, T., Sakata, S., Kita-Okawa, M., Kaneyasu, Y., Inoue, T., Ikeda H, Takekawa, Y., Nakano, T., Wada, S., Fushiki, M., Dokiya, T., Akuta, K., Miyaji, N., Hishikawa, Y., Ogawa, Y., Miyoshi, M., Hareyama, M.: Comparison between high dose-rate and low dose-rate brachytherapy for cervical cancer. Japanese experience with treatment and complications (1975-1985). J Jpn Soc Ther Radiol Oncol, 8(2): 135-142,1996.

Yamazaki, H., Oi, H., Matsumoto, K., Matsushita, M., Ozeki, S., Teshima, T., Murayama, S., Inoue, Ta., Nakamura, T., Inoue, To.: Biphasic changes in serum hepatocyte growth factor after transarterial chemoembolization therapy for hepato-cellular carcinoma. Cytokine, 8(2): 178-182,1996. [Pubmed]

Yamazaki, H., Matsumoto, K., Inoue, Ta., Nose, T., Murayama, S., Teshima, T., Ozeki, S., Koizumi, M., Nakamura, T., Inoue, To.: Induction of hepatocyte growth factor in the liver, kidney and lung following total body irradiation in rat. Cytokine, 8(12): 927-932,1996. [Pubmed]

Yamazaki, H., Inoue, Ta., Koizumi, M., Nose, T., Murayama, S., Teshima, T., Tanaka E., Nose, T., Fukushima, S., Ohashi, K., Inoue, To.: High dose rate brachytherapy using a template technique for pelvic malignancies. Endocurietherapy Hyperthermia Oncol, 12: 145-152,1996.

Yamazaki, H., Inoue, Ta., Nose, T., Murayama, S., Teshima, T., Ozeki, S., Koizumi, M., Inoue, To.: Effect of hepatocyte growth factor on radiation response of HeLa, V79, CHO and primary cultured parenchymal hepatocyte in vitro. Radiation Medicine, 14(2): 81-85,1996. [Pubmed]

Teshima, T., Inoue, Ta., Inoue, To., Ikeda, H., Murayama, S., Yamazaki, H., Ohtani, M., Kishi, K., Miyata, Y.: Symptomatic relief for patients with osseous metastasis treated with radiation and methylpredonizolone: A prospective randomized study. Radiation Medicine, 14(4): 185-188,1996. [Pubmed]

Yamazaki, H., Oi, H., Matsushita, M., Inoue, Ta., Murayama, S., Koizumi, M., Nose, T., Tanaka, E., Teshima, T., Kagawa, K., Inoue, To.: Renal cortical retention of contrast medium after angiography as assessed by delayed CT: Multivariate analysis. Radiation Medicine, 14:5: 247-250,1996. [Pubmed]

Tang, J.T., Yamazaki, H., Nishimoto N., Inoue, T., Nose, T., Koizumi, M., Tanaka E., Ogata A., Yoshizaki, K., Inoue, T.: Effect of radiotherapy on serum level of interleukin 6 in patients with cervical carcinoma. Anticancer Research, 16: 2005-2008,1996. [Pubmed]

Yamazaki, H., Oi, H., Matsushita, M., Inoue, Ta., Teshima, T., Murayama, S., Nose, T., Koizumi, M., Tanaka, E., Inoue, To.: Gallbladder opacification 12-24 h after angiography by CT examination. A multivariate analysis. Abdom Imaging, 21: 507-511,1996.

Teshima, T., Owen, J.B., Hanks, G.E., Sato, S., Tunemoto, H., Inoue, T.: A comparison of the structure of radiation oncology in the United States and Japan. Int. J. Radiat. Oncol. Biol. Phys. 34(1): 235-242,1996.

Inoue, Ta., Inoue, To., Teshima, T., Murayama, S., Shimizutani, K., Fuchihata, H., Furukawa, S.: Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer. Int J Radiat Oncol Biol Phys, 36(5): 1201-1204,1996. [Pubmed]

Yamazaki, H., Oi, H., Matsushita, M., Koizumi, M., Kagawa, K., Tanaka, E., Murayama, S., Nose, T., Teshima, T., Inoue, Ta., Inoue, To.: Focal residual contrast media in the kidney 24 hours after angiography. Acta Radiologica, 37: 348-351,1996. [Pubmed]

Tang, JT, Yamazaki, H., Inoue, Ta., Matsumura S., Fukushima, S., Koizumi, M., Murayama S., Inoue, To., Ozeki, S., Hatanaka, K.: Relative biological effectiveness of 65 MeV proton beam comparing with 137 Cesium gamma rays at Research Center for Nuclear Physics in Osaka University. Med J Osaka Univ, 45: 1-4,1996.

Chatani, M., Matayoshi, Y., Masaki, N., Teshima, T., Inoue, To.: Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field. Strahlenther. Onkol. 172(3): 169-172,1996. [Pubmed]

1995

Murayama, S., Ozeki, S., Tang, J-T., Yamazaki, H., Inoue, Ta., Inoue, To., Fukushima, S., Hatanaka, K., Hosono, K., Shimizu, A., Miura, I., Ejiri, H. and Kanai, T.: Construction of the irradiation system for biological and medical use in RCNP(2). RCNP Annual Report 1994, pp.69-71,1995.

Yamazaki, H., Nishimoto, N., Oi, H., Matsushita, M., Ogata, Y., Inoue, Ta., Yoshizaki, K., Kishimoto, T., Inoue, T.: Serum interleukin 6 as a predictor of the therapeutic effect and adverse reactions after transcatheter arterial embolization. Cytokine, 7(2):191-195,1995. [Pubmed]

Tang, J.T., Yamazaki, H., Inoue, T., Koizumi, M., Kagawa, K., Nose, T., Murayama, S., Mori, M., Takeuchi, E., Ito, M., Ikeda, H., Inoue, T.: Radiotherapy for lung cancer, comparison of results 628 patients treated with palliative and radical treatment. The Cancer Journal, 8(4):201-205,1995.

Yamazaki, H., Oi, H., Matsushita, M., Inoue, Ta., Tang J.T., Inoue, T.: C-reactive protein as an indicator of effect and of adverse reaction to transcatheter arterial embolization. Radiation Medicine, 13(4):163-165,1995. [Pubmed]

Shimizutani, K., Koseki, Y., Inoue, To., Teshima, T., Furukawa, S., Kubo, K., Fuchihata, H., Masaki, N., Ikeda, H., Tanaka, Y.: Application of 198Au grains for carcinoma of oral cavity. Strahlenther. Onkol. 171(1):29-34,1995. [Pubmed]

Inoue, Ta., Inoue, To., Teshima, T., Murayama, S., Yamazaki, H.,Nose, T., Tanaka, E.: Overall time in telecobalt for T1 glottic carcinoma treated with 2 Gy per day. Strahlenther Onkol, 171(8): 475-477,1995. [Pubmed]

Chatani, M., Matayoshi, Y., Masaki, N., Narumi, Y., Teshima, T., Inoue, To.: Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective study. Strahlenther. Onkol. 171(11): 655-660,1995. [Pubmed]

Inoue, Ta., Inoue, To., Teshima, T., Murayama, S., Nose, T., Tanaka, E., Yamazaki, H., Koizumi, M., Kagawa, K., Ozeki, S., Ikeda, H.: Late local recurrence after radiotherapy for tongue and early glottic carcinoma. Strahlenther. Onkol. 172(6):3 01-305,1995. [Pubmed]

Yamazaki, H., Tang, J-T., Inoue, Ta., Teshima, T., Ohtani, M., Ikeda, H., Itou, M., Takeuchi, E., Inoue, To.: Radiographic changes following radiotherapy in the patients with lung cancer. Is the irradiated area of the mediastinum in the simulation film a significant factor? Strahlenther. Onkol. 171(5): 272-277,1995. [Pubmed]

1994

Okawa T, Sakata S, Kita-Okawa M, Kaneyasu Y, Inoue T, Ikeda H, Takekawa Y, Nakano T, Wada S, Fushiki M, Dokiya T, Akuta K, Miyaji N, Hishikawa Y, Ogawa Y, Miyoshi M, Hareyama M: Comparison of HDR versus LDR regimens for intracavitary brachytherapy of cervical cancer. Japanese experience. Brachytherapy from radium to optimization, edited by Mould RF et al. Nucletron International B.V., The Netherlands, pp.60-66,1994.

Ozeki, S., Yamazaki, H., Tang, J-T., Inoue, Ta., Inoue, To., Nose, T., Ohtani, M., Hatanaka, K., Hosono, K., Noro, T., Miura, I., Ejiri, H., Kanai, T.: Construction of the irradiation system for biological and medical use in RCNP. RCNP Annual Report 1993,pp.89-91,1994.

Sugawara, T., Inoue, T., Mori, T.: TBI parameters and relapse of acute leukemia. J Jpn Soc The Radiol Oncol, 6:107-114,1994.

Inoue Ta, Inoue T, Teshima T, Ozeki S, Ikeda H, Murayama S, Yamazaki H, Tang J-T, Ohtani M, Nose T: Prognostic factors of radiation therapy for T3 and T4 laryngeal carcinoma. J Jpn Soc The Radiol Oncol, 6(1):13-19,1994.

Teshima, T., Inoue, T., Inoue, Ta., Ohtani, M., Yamazaki, H., Nose, T., Ozeki, S., Ikeda, H., Murayama, S.: Modified Inoue applicator for endometrial brachytherapy: Radiation Medicine,12:6:285-287,1994. [Pubmed]

Teshima, T., Inoue, T., Ozeki, S., Inoue, Ta., Ohtani, Nose, T., M., Yamazaki, H., Ikeda, H., Murayama, S.: Modified ovoid applicator for intracavitary radiation therapy with a Selectron-MDR or microSelectron-HDR. Radiation Medicine, 12(6):289-291,1994. [Pubmed]

Fuchihata H, Furukawa S, Murakami S, Kubo K, Shimizutani K, Ikeda H, Inoue T, Masaki N: Results of combined external irradiation and chemotherapy of bleomycin or peplomycin for squamous cell carcinoma of the lower gingiva. Int J Radiat Oncol Biol Phys, 29(4):705-709,1994. [Pubmed]

Inoue, Ta., Inoue, T.: ISDN application for image transmission. Comput. Methods Programms Biomed. 43:139-144,1994.

Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Iwanaga T, Matayoshi Y, Inoue T: Is the long-term survival rate improved by preoperative irradiation prior to Whipple's procedure for adenocarcinoma of the pancreatic head? Arch. Surg. 129:1075-1080,1994.

Chatani, M., Matayoshi, Y., Masaki, N., Teshima, T., Inoue, T.: Long term follow-up results of high-dose rate remote afterloading intracavitary radiation therapy for carcinoma of the uterine cervix. Strahlenther Onkol: 170(5):269-276,1994. [Pubmed]

Chatani, M., Matayoshi, Y., Masaki, N., Teshima, T., Inoue, T.: A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results. Strahlenther Onkol, 170(11):636-642,1994. [Pubmed]

1993

Teshima T, Inoue Ta, Inoue T, Ikeda H, Sasaki S, Yamazaki H, Ohtani M, Murayama S, Kozuka T: High-dose rate intracavitary therapy for cervical cancer with a microSelectron. A preliminary report. Radaition Medicine, 11(6):237-241,1993. [Pubmed]

Teshima T, Inoue Ta, Inoue T, Ikeda H, Yamazaki H, Ohtani M, Sasaki S, Murayama S, Kozuka T: Mid-dose rate intracavitary therapy for cervical cancer with a Selectron. A preliminary report. Radiation Medicine, 11(6):242-246,1993. [Pubmed]

Teshima, T., Inoue, T., Ikeda, H., Murayama, S., Yamasaki, H., Sasaki, S.: The Inoue applicator for endometrial brachytherapy. Activity, International Selectron Brachytherapy Journal, 7(1):17-18,1993.

Inoue, Ta., Matayoshi, Y., Inoue, To., Ikeda, H., Teshima, T., Murayama, S.: Prognostic factors in telecobalt therapy for early supraglottic carcinoma. Cancer, 72(1):57-61,1993. [Pubmed]

Teshima, T., Inoue, To., Ikeda, H., Miyata, Y., Nishiyama, K., Inoue, Ta., Murayama, S., Yamasaki, H., Kozuka, T.: High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix, Final results of Osaka University Hospital. Cancer, 72(8):2409-2414,1993. [Pubmed]

Ikeda, H., Inoue, T., Teshima, T., Murayama, S., Kozuka, T., Aozasa, K.: Treatment of indolent non-Hodgkin's lymphoma localized in the head and neck. Am. J. Clin. Oncol. 16(1):72-76,1993. [Pubmed]

Inoue, T., Ikeda, H., Yamazaki, H., Tang, J.T., Song, C., Teshima, T., Murayama, S., Ohtani, M., Shibata, H., Masaoka, T.: Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission. Strahlenther. Onkol. 169(4):250-255,1993. [Pubmed]

Inoue, Ta., Inoue, To., Ikeda, H., Teshima, T., Murayama, S., Yamazaki, H., Otani, M.: Prognostic factor of radiotherapy for squamous cell carcinoma of oropharynx without clinically positive nodes. Strahlenther. Onkol. 169(8):476-480,1993. [Pubmed]

Yamazaki, H., Inoue, To., Ikeda, H., Tang, J.T., Murayama, S., Teshima, T., Ohtani, M., Kozuka, T.: High-dose-rate remote afterloading interstitial radiotherapy employing the template technique for recurrent cancer in the pelvic area. Strahlenther. Onkol. 169(8):481-485,1993. [Pubmed]

Teshima, T., Inoue, Ta., Inoue, To., Ikeda, H., Yamazaki, H., Ohtani, M., Shimizutani, K., Furukawa, S., Kozuka, T., Murayama, S.: Radiation therapy for carcinoma of the major salivary glands. Results of conventional irradiation technique. :Strahlenther. Onkol. 169(8):486-491,1993. [Pubmed]

Inoue, Ta., Inoue, To., Ikeda, H., Teshima, T., Yamazaki, Murayama, S., Otani, M., Ozeki, S.: Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy. Strahlenther. Onkol. 169(10):584-589,1993. [Pubmed]

Chatani, M., Matayoshi, Y., Masaki, N., Inoue, Ta., Teshima, T., Inoue, To.: Radiation therapy for early glottic carcinoma, indication for the wedge filter. Strahlenther. Onkol. 169(11):655-659,1993. [Pubmed]

Chatani, M., Matayoshi, Y., Masaki, N., Inoue, T.: Radiation therapy for brain metastases from lung carcinoma, Prospective randomized trial according to the level of lactate dehydrogenate. Strahlenther. Onkol. 170(3):155-161,1993. [Pubmed]

1992

Okawa T, Sakata S, Kita-Okawa M, Kaneyasu Y, Inoue T, Ikeda H, Takekawa Y, Nakano T, Wada S, Fushiki M, Dokiya T, Akuta K, Miyaji N, Hishikawa Y, Ogawa Y, Miyoshi M, Hareyama M: Comparison of HDR versus LDR regimens for intracavitary brachytherapy of cervical cancer. Japanese experience. International Brachytherapy, ed by RF Mould, Nucletron International B.V., Veenendaal, Netherlands, pp.13-17,1992.

Teshima, T., Inoue, T., Ikeda, H., Murayama, S., Yamasaki, H., Sasaki, S.: The Inoue applicator for endometrial brachytherapy. International Brachytherapy, ed by RF Mould, Nucletron International B.V., Veenendaal, Netherlands, pp.193-196,1992.

Teshima, T., Inoue, T., Ikeda, H., Murayama, S., Furukawa, S., Shimizutani, K.: Interstitial HDR brachytherapy for head and neck cancer. Case history reports. International Brachytherapy, ed by RF Mould, Nucletron International B.V., Veenendaal, Netherlands, pp.423-426,1992.

Inoue, T., Ikeda, H., Teshima, T., Murayama, S., Yamasaki, H.: Cancer incidence in Japan with special reference to tumour sites treated by brachytherapy. International Brachytherapy, ed by RF Mould, Nucletron International B.V., Veenendaal, Netherlands, pp.561-564,1992.

Takashima, S., Noguchi, Y., Takeuchi, N., Tomiyama, N., Johkoh, T., Inoue, T., Okumura, T., Kozuka, T.: Head and neck carcinoma. Detection of extraorgan spread with MR imaging and CT. Europ. J. R. 14:228-234,1992.

Inoue, Ta., Inoue, To., Ikeda, H., Teshima, T., Murayama, S., : Fraction size of telecobalt therapy for T1 glottic carcinoma. J. Jpn, Soc. Ther. Radiol. Oncol. 4(2):95-100,1992.

Teshima, T., Inoue, T., Ikeda, H., Murayama, S., Furukawa, S., Shimizutani, K.: Phase I/II study of high-dose rate interstitial radiotherapy for head and neck cancer. Strahlenther. Onkol. 168(11):617-621,1992. [Pubmed]

Inoue, Ta., Inoue, To., Chatani, M., Teshima, T.: Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma. Strahlenther. Onkol. 168(1):1:23-26,1992. [Pubmed]

Teshima, T., Inoue, To., Chatani, M., Hata , K., Hiyama, T., Ikeda, H., Murayama, S.,: Incidence of other primary cancers in 1,569 patients with pharyngolaryngeal cancer and treated with radiation therapy. Strahlenther. Onkol. 168(4):213-218,1992. [Pubmed]

Inoue, Ta., Inoue, T., Ikeda, H., Teshima, T., Murayama, S.: Prognostic factor of telecobalt therapy for early glottic carcinoma. Cancer, 70(12):2797-2801,1992. [Pubmed]

Inoue, Ta., Inoue, T., Ikeda, H., Teshima, T., Murayama, S. : Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma. Strahlenther. Onkol. 168(10):579-583,1992. [Pubmed]

Teshima, T., Sasaki, J., Chatani, M., Inoue, T.: A new breast bridge for the radiation treatment planning of early breast cancer. Radiography Today, 58(661):19-20,1992.

1991

Hishikawa, Y., Miura, T., Oshitani, T., Yoshimura, H., Ono, K., Takahashi, M., Nakajima, T., Murakami, M., Ikeda, H., Imanaka K., Chatani, M., Inoue, T.: A randomized prospective study of adjuvant chemotherapy after radiotherapy in unresectable esophageal carcinoma. Diseases of the esophagus:4(2):85-90,1991.

Teshima, T., Chatani, M., Inoue, T., Miyahara, H., Tsuruta, Y., Yoshino, K., Sato, T., Shibata, H.: Radiation therapy for primary non-Hodgkin's lymphoma of the head and neck. Radiation Medicine, 9(1):29-34,1991. [Pubmed]

Ishikawa, O., Ohigashi, H., Imaoka, S., Teshima, T., Inoue,T., Sasaki, Y., Iwanaga, T., Nakaizumi, A.: Concomitant benefit of preoperative irradiation in preventing pancreas fistula formation after pancreaticoduodenectomy. Arch Surg.126:885-889,1991.

Fujita, M., Sato, K., Sato, M., Inoue, T., Kozuka, T., Tohyama, M.: Regional distribution of the cells expressing glycine receptor beta subunit m RNA in the rat brain. Brain Research, 560:23-37,1991. [Pubmed]

Chatani, M., Teshima, T., Inoue, T., Yoshino K., Ikegami, N., Hirai K., Shimakage, M.,: Antibody response against the Epstein-Barr Virus-coded Nuclear Antigen 2 (EBNA2) in nasopharyngeal carcinoma. Laryngoscope:101(6):626-629,1991. [Pubmed]

Chatani, M., Teshima, T., Inoue, T.: A prospective randomized study concerning to the point A dose in high-dose rate intracavitary radiation therapy for carcinoma of the uterine cervix. Strahlenther. Onkol. 167(12):701-707,1991. [Pubmed]

1990

Inoue, T., Chatani, M., Teshima, T., Hata, K., Harada, K.:Combined external beam and high-dose-rate brachytherapy for nasopharyngeal cancer. Afterloading brachytherapy I, edited by Kutzner, J.W., Zuckschwerdt, München, pp.175-179,1990.

Inoue, T., Teshima, T., Chatani, M., Hata, K., Inoue, Ta.: Interim report of a prospective randomized study of fractional dose in high-dose-rate intracavitary therapy for carcinoma of the uterine cervix. Afterloading brachytherapy I, edited by Kutzner, J. W., Zuckschwerdt München, pp.87-91,1990.

Teshima, T., Inoue, T., Chatani, M., Ikeda, H., Nishiyama, K., Matayoshi, Y., Hishikawa, Y., Tanaka, S., Kamikonya, N., Miyata, Y.: Radiation therapy of the para-aortic lymph nodes in carcinoma of the uterine cervix. The concurrent use of cimetidine to reduce acute and subacute side effects from radiation. Clin. Therap.12(1):71-77,1990. [Pubmed]

Teshima, T., Chatani, M., Inoue, T.: Radiation therapy for early glottic cancer (T1NOMO). II. Prospective randomized study concerning radiation field. Int. J. Radiat. Oncol. Biol. Phys. 18(1):119-123,1990. [Pubmed]

Sawada, M., Inagaki, M., Ozaki, M., Yamasaki, M., Nakagawa, H., Inoue, T., Terada, N., Wada, A.: Long-term survival after brain metastases from endometrial cancer. Jpn. J. Clin. Oncol. 20(3):312-315,1990. [Pubmed]

Inoue, T., Masaoka, T., Shibata, H.: Difference in onset between cytomegalovirus and idiopathic interstitial pneumonitis following allogeneic bone marrow transplantation. Strahlenther. Onkol. 166(5):322-325,1990. [Pubmed]

Teshima, T., Chatani, M., Inoue, T., Hirokawa, Y., Wadasaki, K., Kashiwado, K., Kagemoto, M., Katsuta, S., Honke, Y., Koyama, T., Makidono, Y., Katayama, H., Kiso, T.: Prognostic factors for patients with osseous metastasis. A multiinstitutional prospective study. Strahlenther. Onkol. 166(6):387-391,1990. [Pubmed]

Chatani, M., Teshima, T., Hata, K., Inoue, T. : Prognostic factors in patients with brain metastases from lung carcinoma. Preliminary result of the second trial. Strahlenther. Onkol. 166(8):562-567,1990. [Pubmed]

研究紹介